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Abstract: Bovine Viral Diarrhea Virus (BVDv) is a disease that has effects that are not 
identified by the majority of operations in the beef industry. This research is designed to 
evaluate the cost of the disease at every level and compare that to the cost of 
implementing an enhanced control system. By evaluating the cost of vaccination and 
eradication versus morbidity and mortality from cow-calf operations, 
feeder/backgrounding operations, and feedlot operations a base partial budgeting model 
can be used to determine the cost of BVDv on each individual operation and the cost of 
vaccination and eradication. A cost-benefit analysis on every level will determine if 
enhanced control is a cost-effective endeavor for the industry. This will indicate that 
feedlots and stockers would benefit from providing a monetary incentive to cow-calf 
producers to vaccinate and eradicate possibly infected animals would be plausible. This 
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Throughout history, there have been many diseases that have impacted the cattle industry. 
Over time, vaccines have been developed and certain diseases have been eradicated. For many 
years, the cattle industry has been affected by Bovine Viral Diarrhea virus (BVDv) on every level 
from the cow-calf operations to stocker/backgrounding and then on to feedlot operations. 
Estimations of the annual cost of BVDv to the cattle industry ranges from $500 million to $1.9 
billion dollars (Miles, 2009) (Ishmael, 2013).  Determining the economic impact of Bovine Viral 
Diarrhea in the beef industry and the economic feasibility of enhanced control at the cow-calf 
level is necessary to determine if controlling the disease is cost-effective to the beef industry. The 
economic impact caused by Bovine Viral Diarrhea is not fully recognized and is costing 




Bovine Viral Diarrhea Virus (BVDv) is a disease that affects every level of the beef 
industry. At the cow-calf level, pregnant cattle that are infected have abortions and premature 
births. Calves infected in the fetus, are born as Persistently Infected (PI) calves and a majority do 
not live to weaning. This reduces the number of calves sold which in turn reduces income. If the 
PI calves survive weaning, they are usually sold to a stocker/feedlot operation. Once cattle are at 
a stocker/feedlot operation, commingling occurs. The PI cattle then expose many other cattle that 
may be susceptible to the disease. This causes an increase in cattle sickness and death loss. PI 
cattle are often chronically ill and perform poorly in normal conditions where healthy cattle 
typically thrive. There is a high mortality rate throughout chronically PI cattle and every sector 
loses money from PI cattle.  
This research will be using different categories of respiratory diseases. The terms are 
difficult to decipher and keep straight, therefore this is designed to help understand the 
differences in the terms. BVDv is the main focus of this research which examines how the 
implementation of an enhanced disease control program will impact the beef industry. BVDv-PI 
cattle are cattle that have BVDv as a chronic illness and shed the disease for the entirety of their 
lives, even when asymptomatic. BVDv acute infection occurs when a BVDv-PI animal infects 
another animal. BRD or Bovine Respiratory Disease is the disease that BVDv is closely 
associated with. Therefore literature and resources are closely related to each other and some 
assumptions are pulled from BRD research. BRD is a complex disease that BVDv is often 
incorporated with. This makes finding specific information only regarding BVDv difficult. 
Prevalence is the percentage of herds or operations that have a BVDv positive animal. Incidence 
is the percent of animals that are infected in those individual operations.  
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Estimated losses that are associated with BVDv have a wide range across multiple 
sources and databases. Estimated outbreaks of BVDv in a cow herd has a general cost estimate of 
$50-$100 per cow (USDA APHIS, 2007). Severe outbreaks that occurred in Canada in 1998 had 
estimated costs of $40,000-$100,000 per herd or $400 per cow (USDA APHIS, 2007). However, 
Bovine Respiratory Disease (BRD) is estimated to cost the cattle industry a total of $500 million 
per year (Miles, 2009). The total cost of BVDv was estimated at $1.9 billion annually in 2011 
(Ishmael, 2013). Another source states that BVDv costa both the beef and dairy industry upwards 
of $3 billion each year (Animal Health, 2016). These evaluations include morbidity, mortality and 
production losses caused by the disease. The variation of these estimations are attributed to the 
different factors and costs associated with the disease.  
In spite of the high costs associated with BVDv, BVDv-PI and BRD, increased control 
has not occurred. The costs are largely attributed to the stocker and feedlot levels, however, cow-
calf operations are the critical stage in controlling the disease. This has created disconnect 
between the willingness to incur costs to control the disease and the benefits of the enhanced 
control between these sectors that are not distributed equally. 
While industry-wide costs of BVDv have been assessed, the costs have not been 
determined for each individual sector. Evaluating BRD, BVDv, and BVDv-PI cattle will 
determine if the cost of vaccination and enhanced control is feasible. This research will help 
identify the economic impact caused by Bovine Viral Diarrhea virus and the cost of eradication 
versus the benefits of enhanced disease control for each sector and the incentives required to 










The overall objective of this research is to determine the economic impact of BVDv within 
individual sectors of the beef cattle industry and the feasibility of control/eradication programs. 
Specific objectives of this research were: 
1. Determine the incidence and distribution of Bovine Viral Diarrhea virus in cow-calf, 
stocker and feedlot sectors. 
2. Determine the use and efficacy of emerging diagnostic and control technology (testing, 
vaccines, eradication) for BVDv. 
3. Determine the costs borne by each sector resulting from the disease compared to the 
benefit of enhanced control in each sector. 






REVIEW OF LITERATURE 
BVDv can vary greatly in its presentation in cattle from cow-calf operations to stocker to 
feedlot operations, with detrimental impacts every level (Kerr, Hopkins, and Welborn, 2001). 
Symptoms range from fever, depression, diarrhea, respiratory disease, runny nose/eyes and can 
end in either a full recovery or death. Whether cattle survive is dependent on several factors; 
including: immune status of the animal, the strain of infection, and age of the animal (Stokka, et. 
al 2000). Determining what this disease is costing the beef industry as a whole is necessary to 
determine the economic impact of Bovine Viral Diarrhea on the beef industry. 
BVDv (The Disease) 
 Bovine Viral Diarrhea Virus or BVDv is a respiratory disease that affects the immune 
systems of cattle. BVDv is one of several disease organisms that make up the Bovine Respiratory 
Disease (BRD) complex (See page 10). The term BVDv refers to a heterogeneous group of 
viruses that belong to two different species, BVDv1 and BVDv2, within the pestivirus genus of 
the Flavivirus family. BVDv has two sub biotypes, cytopathic (CP) and noncytopathic (NCP). 
Distinction is based on the characteristics of the virus when grown in a laboratory in tissue 
culture. The strain of BVDv1a is considered the NCP strain. This strain reproduces without 




possibility of survival even though it is infected. The CP type results in the death of target cells 
and death of the animal which represents the remaining 5 percent of the field isolates. These 
antigenic variations of the viral surface proteins are the result of the two BVDv types, type 1 and 
type 2 (Ridpath, 2010 ‘B’). Fetal infection can lead to early embryonic death, abortion, congenital 
defects, the birth of Persistently Infected (PI) calves, or the birth of normal calves. The immune 
status of the dam, the stage of gestation at the time of infection, and the viral biotype are 
important factors in determining the result of vertical infection (Larson, 2015). The majority of 
BVDv infections are subclinical, with the severity of disease determined by the type of strain and 
the hosts’ susceptibility. However, BVDv infections almost always produce some degree of 
immunosuppression determined by the virus of the infecting strain. If the animal is exposed to 
other pathogens while it is immunosuppressed, morbidity and death-loss will most likely be 
greatly increased. Initial infection is in the respiratory or vaginal mucosa, followed by systemic 
viral replication and widespread infection of the immune, respiratory, reproductive, and enteric 
systems (Wittum, et. al. 2001). Infected cattle shed BVDv in various body fluids and tissues 
including saliva, nasal discharge, blood, feces, urine, and aborted fetal tissues throughout their 
infection. Persistently infected animals can shed more viruses and for their entire lives while 
acutely infected cattle only shed while they are contagious (Larson, 2015).  
The incidence and infection rate of BVDv-PI cattle throughout the United States is 
relatively low. With approximately 4 percent of herds across the United States having at least 1 or 
more PI animals in their herds and the incidence rate within the herd being approximately 0.3 
percent, the disease’s severity is underestimated (Mason, et. al. 2005). From the 2012 Census of 
Agriculture report, the total number of beef farms that contained cows and heifers that calved was 
727,906 (USDA NASS, 2012). BVDv is transmitted within a herd or during comingling in two 
different ways. The first way to pass the disease from one animal to another is through bodily 
fluids when an animal is infected and sheds the virus (horizontal). The second method is when a 
7 
 
dam infects the fetus during pregnancy (vertical). Horizontal transmission or acute infection of 
BVDv results in a temporary (transient) infection or acute infection that is usually mild but can 
result in severe disease. Vertical transmission results in either death or PI animals that carry and 
shed the disease for the entirety of their lives (Larson et. al., 2005). Historically, virus isolation in 
cultured bovine cells has been the standard against which other tests were evaluated. Vaccination 
is effective in reducing the spread of BVDv but cannot on its own eliminate BVDv from 
populations (Ridpath, 2010 ‘A’). Direct contact with animals is the most common form of 
transmission since the virus does not survive an extended period in the environment. Infection 
during the breeding season could result in abortion or infertility. Infection during the first half of 
gestation could result in abortions or the birth of persistently infected calves. Infection during the 
second half of gestation could result in abortions, birth defects, stillbirths or weak calves 
(Strickland, 2017). Although abortions and weak calves have been attributed to BVDv infection 
in late gestation, infections occurring earlier in gestation generally have a greater impact on 
reproduction (Ridpath, 2010 ‘B’). Diagnosis may be made on clinical signs that are typical of the 
viral respiratory disease, including fever, depression, loss of appetite, and ocular and nasal 
discharge, followed by diarrhea several days after onset. Sores or ulceration in the mouth and 
gums may be present, along with reduced milk production in cows.  Virus isolation from blood, 
milk, and tissues is useful in diagnosing BVDv (Stokka, et. al 2000). Persistently infected animals 
(PIs) may appear normal or may suffer from an array of congenital anomalies, including defects 
of the nervous system, eyes, skeletal system, and skin/hair.  BVDv is implicated as a cause of 






Persistently Infected Animals 
The principal reservoir of BVDv is Persistently Infected (PI) animals. PI cattle are more 
likely than normal cattle to require treatment for respiratory tract disease and can become 
chronically ill or die (Ridpath, 2010 ‘A’). The PI animal also has a high risk of succumbing to a 
highly fatal form of BVDv called mucosal disease (BVDv-MD). BVDv-MD is the sequela of a 
persistent infection with non-cytopathic BVDv strain, followed by an acute concurrent infection 
with a cytopathic BVDv strain. The clinical presentation of the reproductive disease is due to the 
direct infection of the fetus and the outcome depends on the stage of gestation in which the fetal 
infection occurs. Exposure to bovine viral diarrhea viruses (BVDv) results in acute and persistent 
infections. Persistent Infections result from in utero exposure during the first trimester of 
gestation. The clinical presentation in persistently infected cattle (PI) is highly variable. The 
reasons for this variation is largely unknown. The BVDv circulating in PI exist as quasi-species 
(swarms of individual viruses). In one study, an outbreak that resulted in 34 PI cattle presented an 
opportunity to compare a large number of PI's in a herd environment. Scientific methods were 
developed to compare the circulating viral populations within PI animals. The results found that 
PI animals generated in the same outbreak were carrying circulating viral populations that differ 
widely in size and diversity. Further, it was demonstrated that variation in PI viral populations 
could be used as a quantifiable phenotype. This observation makes it possible to test the 
correlation of this phenotype to other phenotypes such as growth rate, congenital defects, viral 
shed and cytokine expression (Ridpath, et al. 2015). 
The objective of another study was to estimate the prevalence of cattle persistently 
infected (PI) with bovine viral diarrhea virus (BVDv) at arrival at a feedlot, prevalence of 
chronically ill and dead PI cattle, and the magnitude of excess disease attributable to a PI animal 
(Larson, 2015). Most feedlot cattle in the United States are administered a BVDv containing 
vaccine upon arrival of a feedlot. However, well-controlled vaccine efficacy studies conducted in 
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real-world settings are generally lacking. This study included cross-sectional and cohort studies. 
The study included 2,000 cattle and at the time that they arrived at the feedlot, there were 1,383 
chronically ill cattle from 7 feedlots, and 1,585 dead cattle from a single feedlot. The procedure 
that was used to conduct the study included sample collection and processing. Skin biopsy 
specimens were collected and evaluated via immunohistochemistry. Cattle were characterized as 
either PI or non-PI with BVDv on the basis of characteristic immunostaining. Follow-up testing 
was obtained for the 2,000 cattle sampled at arrival, and health outcomes were determined for 
cattle exposed and not exposed to a PI animal. The results indicated that the prevalence of PI 
cattle was 0.3 percent at arrival, 2.6 percent in chronically ill cattle, and 2.5 percent in dead cattle. 
Risk of initial treatment for respiratory tract disease was 43 percent greater in cattle exposed to a 
PI animal, compared with those not exposed to a PI animal. Overall, 15.9 percent of initial 
respiratory tract disease events were attributable to exposure to a PI animal. In conclusion, 
relatively few PI cattle arrive at feedlots. However, those cattle are more likely to require 
treatment for respiratory tract disease and either become chronically ill or die than cattle that are 
not PI. In addition, they are associated with an increase in the incidence of respiratory tract 
disease of in-contact cattle (Mason, et. al. 2005). 
The determination of the total impact of persistently infected animals must factor in the 
contribution of acute, uncomplicated BVDv infections. The impact of the respiratory disease in 
animals persistently infected with BVDv results in the immunosuppression that accompanies 
acute BVDv infections and this leads to animals being susceptible to secondary infections 
(Ridpath 2010 ‘B’).  Feedlots and stocker operations are at a higher risk due to the increased 
amount of commingling that occurs within the feedlots as well and through auctions and 





Bovine Respiratory Disease 
Typically, BVDv is grouped with Bovine Respiratory Disease (BRD) because the 
diseases are similar, and most current literature focuses heavily on BRD. BRD accounts for 
approximately 70 percent of feedlot morbidity and 50 percent of feedlot mortality, negatively 
affecting profit. United States Department of Agriculture (USDA) National Animal Health 
Monitoring System (NAHMS) Beef Feedlot 2011 Study (USDA, 2013) reports that the direct 
cost of treatment of respiratory disease in feedlot cattle is USD $23.60 per case. The total cost of 
treating 2.29 million cattle for respiratory disease is, therefore, estimated to be USD $54.12 
million, not including production losses due to morbidity and mortality. Reducing BRD 
prevalence would result in increased supplies of beef cattle through lower morbidity and 
mortality rates (Johnson and Pendell, 2017).  
The North American beef cattle industry has endured many changes throughout the years 
but is encountering some of the most dramatic challenges in history during the first decade of the 
21st century. The US beef cattle inventory increased from 1990 to a high of 103.5 million in 1996 
and since has declined to a low of 94.5 million on 1 January 2009. Even though economic signals 
have encouraged the cow herd to increase over the last 5 years, a significant decrease occurred 
during 2008. It is difficult to determine the precise cost of bovine respiratory disease (BRD) to 
the industry but it is reported to be greater than US$500 million per year.  
“Data from our practice indicate that losses from BRD over the last 18 years have been 
characterized by 5-year cycles of decreases and increases. Perhaps it is time for the industry to 
look for ways to reduce death loss by methods that focus on the animal's response to the 
pathogens instead of continuing to focus on the pathogens” (Miles, 2009). 
BVDv has multiple symptoms that are attributed not only to BVDv but also to respiratory 
infections such as BRD, with signs similar to Infectious Bovine Rhinotracheitis (IBR), plus oral 
and tracheal ulceration Thrombocytopenic (bleeder) syndrome, where type 2 BVDv infects blood 
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cells and bone marrow, causing destruction of red blood cells, reduced clotting function, bleeding 
from wounds, lesions, and internal organs as well as reproductive diseases resulting in embryonic 
loss and abortions. Persistent infection (PI), which results when a calf is infected in utero with 
NCP BVDv during the first trimester of gestation and survives, and results in a continuing 
reservoir of BVDv infection. Animals with PI are often outwardly normal. Mucosal 
disease occurs when an animal with PI is exposed to a CP strain of BVDv, resulting in explosive 
diarrhea and ulceration throughout the digestive tract and in most cases, death. When cattle are 
immunosuppressed with BVDv, they are 68 percent more likely to suffer from additional diseases 
attributed to BRD (Fulton et. al., 2006).  
Many predisposing factors have been implicated in reducing the death-loss impact 
including stress from weaning, transportation, mixing of cattle, handling, and processing. Viruses, 
including parainfluenza-3, bovine respiratory syncytial virus, bovine herpes virus-1, coronavirus, 
and BVDv. All of these issues have been implicated as predisposing causes of BRD (Brooks, et. 
al. 2011). Respiratory infection with BVDv is characterized by signs typical of the viral 
respiratory disease, including fever, depression, lack of appetite, and eye and nasal discharge, 
sores or ulceration in the mouth and gums may be present, along with reduced milk production in 
cows (Stokka, et. al 2000). Typically, once an animal is infected or susceptible to BVDv then the 
immune system is compromised and a variant on its ability to fight off additional infections 
which leaves extensive room for BRD to manifest. 
The cost of eradicating and vaccinating for the disease is a huge issue that the cattle 
industry is attempting to address (Vestal, Richeson, 2014). BRD can cause significant economic 
losses for cattle producers. On average, producers lost approximately $122 per head (Brooks, et. 
al. 2011). However, by testing three different herd levels versus three different levels of 
prevalence, it was determined that testing for BVDv is not necessarily economically efficient. 
Testing a whole herd for BVDv is a significant cost to producers. When a herd is infected with PI 
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cattle, it is slightly beneficial cost wise to test for BVDv. Since this study was conducted, there 
have been many advances in the testing industry that is making the testing strategies cost less and 
less, however, it is still considered to be a loss to producers to test. This may not always be the 
case in the future with more advanced technology. When there are no PI cattle, then testing is 
considered a negative value for producers. Overall, this study revealed that implementing whole 
herd testing strategies for BVDv is rarely a beneficial economic endeavor (Nickell, et. al. 2011). 
The likelihood of PI cattle being in herds is at a low enough percentage that farmers would not 
typically assume the cost to screen for BVDv (Larson, et. al. 2002). 
Cow-Calf Impacts 
The impact that BVDv can have on a beef herd is tremendous and often goes undetected. 
Even mild or subclinical infections of susceptible breeding females can cause conception failure, 
early embryonic loss, abortion, or vertical fetal infection. Most BVDv infections occur in the first 
trimester of gestation leading to calves that are in turn persistently infected (Larson, 2015). 
Persistently infected cows always give birth to PI calves and are much more likely to infect other 
cows who will, in turn, give birth to PI calves (Stokka, et. al. 2000). The presence of multiple PI 
calves in a herd suggests the presence of multiple susceptible females in the herd as well as 
possible PI cows. Herds with PI calves had a 3 percent lower pregnancy rate than non-PI infected 
cattle. Persistently infected calves that survive to weaning provide a constant source of the 
disease to the rest of the herd and could result in more PI calves born every year without proper 
intervention (Wittum, et. al. 2001). 
Another study determined the prevalence of bovine viral diarrhea virus (BVDv) in 
persistently infected (PI) cattle in beef breeding herds using 30 herds with 4530 calves (Grooms 
et. al. 2001). The samples were collected by ear notches and tested for BVDv antigens using 
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immunohistochemistry (IHC) and antigen capture enzyme-linked immunosorbent assay (ACE). 
This was the most effective way to test for BVDv-PI animals in a herd environment. 
Current marketing of cattle and delivery of cattle to the feedlot represents a major 
potential for PI cattle to enter a feedlot. For example, a recent study demonstrated that of 21,743 
cattle entering a feedlot, 0.4 percent were PI (Fulton, et al. 2009). These cattle were purchased by 
order buyers from 10 southern and southeastern states and were delivered into 240 separate pens, 
74 (30.8 percent) of these pens had a PI animal. Thus, the goals for cattle entering the feedlot 
should be high and effective immunity to BVDv, but it is also important for the cattle to be free of 
exposure to PI cattle (Fulton, et al. 2009). Detecting and eliminating persistently infected cattle is 
used as a method to control BVDv in infected herds and prevent the introduction of BVDv into 
non-infected herds.  
Persistent infection develops after in-utero exposure to BVDv that result in 
immunotolerance. Therefore, among the 1,952 cattle tested in the study, BVDv was detected in 5 
cows (0.26 percent) from the 3 of the 13 farms (Grooms et. al. 2001). In each of the 5 cows, the 
virus was detected in serum and white blood cell count (WBC) preparations. BVDv was again 
isolated from serum and WBC preparations from each of the 5 cows, indicating that these cattle 
were persistently infected with the virus. No cows were found in which BVDv could only be 
isolated from WBC and not serum (Grooms, et. al. 2001). 
Stocker and Feedlot Impacts 
An even larger impact than impact on cow-calf operations is inflicted on stocker and 
feedlot operations. The US Department of Agriculture estimates 10.7 million cattle were placed 
on feed in the United States in 2016 and 2.0 percent of cattle (214,000 head) placed on feed either 
died or were sent to market before reaching desired slaughter weight (Ridpath, 2010 ‘A’). In 
addition to the direct losses of BVDv-PI cattle, feedlots may experience losses among non-PI 
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cattle that are transiently infected with BVDv due to virus transmission from PI cattle. 
Transmission of BVDv from PI cattle to in-contact susceptible cattle occurs during marketing, 
trucking, and while in feeding pens and pastures. Vaccination against BVDv antigens at the time 
cattle arrive at a feedlot as well as earlier in the cattle production system is a common 
intervention to reduce the biologic and economic costs of BVDv in feedlot cattle. A small 
percentage of cattle are BVDv-PI with and constitute the primary reservoir for the virus; 
however, they shed the virus and can cause immunosuppression in up to 79 percent of a herd or 
operation. Testing and removal of PI cattle at feedlot arrival or earlier can effectively remove 
nearly all the BVDv reservoir from the population even if the test returns a few false-negative 
results (Larson 2015).  
The economic cost of BVDv-PI cattle at feedlot arrival will depend on the prevalence of 
PI cattle (Larson, 2015). If BVDv makes it into feed yards, the disease can cost $31-$41 per head. 
That amounts to costing the industry about $3 billion each year. BVDv testing costs $2.50 - $3.50 
per head depending on the number of samples tested and the size of the pools. According to 
Superior Livestock Auctions, buyers paid about $2.42 more per hundredweight for BVDv-PI 
tested calves at auction. This is approximately $10 per head net profit for tested cattle. In one 
example: a 10,000-head feedlot was tested. There was only about 0.4 percent prevalence but 72 
percent of the pens were exposed to the disease. The observed cost of the disease per animal was 
$47.92, resulting in a cost to the feedlot of $479,200 compared to testing costs of $35,000 
(Animal Health, 2016). BVDv is most often found in cattle younger than 2 years of age and 
affects multiple body systems of the animal decreasing the immune system’s ability to fight 
infections. As a result, feedlot and stocker producers face relatively higher production costs with 
the presence of BVDv due to poor feed conversion and higher mortality since 90 percent of their 
cattle are under 2 years of age. Because the prevalence of BVDv can vary, it is estimated that 
exposing a general population of feedlot cattle to PI animals’ costs $67.49 per head due to 
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performance losses and fatality (Williams, Corbin, Blue, 2013). Testing and control of PI-BVDv 
continue to be a challenge for the cattle industry. As stocker and feedlot producers continue to 
face tighter profit margins, the cost of testing for BVDv does not seem feasible or necessary 
(Vestal, Richeson 2014). This is why the economic cost of PI cattle in feedlot operations, and the 
value of removal of PI cattle after test results should be determined (Larson, 2015). Ultimately, 
control of this pathogen will rest with the cow-calf industry. The use of pre-breeding vaccines 
with modified live vaccines that can demonstrate fetal protection will be the most significant tool 
currently available to eliminate the presence of PI calves. Enhanced BVDv biosecurity programs 
that effectively identify and remove PI cattle from herds and prevent their introduction will be 
critical to controlling the disease at all levels of the industry. The widespread availability of 
immunohistochemical tests for BVDv will provide a sensitive means for which producers to 
accomplish this goal. Voluntary BVDv eradication programs and herd certification programs 
could give feedlot operators a source of calves that will be at a lower risk for containing PI 
calves. In combination with pre-vaccination programs, these types of efforts may provide an 
opportunity to decrease the role that BVDv plays in infectious disease of feedlot cattle (Campbell, 
2004). 
In one study, 7,544 stocker calves purchased from an order buyer from auction markets in 
Alabama, Florida, Georgia, Mississippi, and Tennessee were sampled from March to December 
2005 (Stephenson, et al. 2017). Following the purchase, calves were transported to a central 
holding facility where the calves were processed, sorted, and assembled into 28 truckload lots 
based on average body weight. Skin biopsies (ear notches) were collected in zinc-buffered 
formalin for the detection of BVDv persistent infection using immunohistochemistry. Twenty-
four BVDv-positive calves were detected in a sampling of 7,544 calves. The overall BVDv PI 
prevalence in stocker calves sampled was measured at 0.318 percent. Therefore, with 95 percent 
confidence, the BVDv-PI prevalence was between 0.19 percent and 0.45 percent. This prevalence 
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aligned closely with the BVDv PI prevalence rates that have been reported previously in other 
regions of the United States (Stephenson, et al. 2017).  In this study, calves weighing less than 
180 kg had greater BVDv PI prevalence with 2.78 times greater probability of being PI animals 
compared with calves over 180 kg. Interestingly, Southeastern United States cattle are widely 
considered to be at a high risk of disease by feedlot managers. This might be associated with 
stress induced by long-distance travel impairment of immune responsiveness, a low percentage 
(59.8 percent) of operations using vaccines, or presence of PI animals, resulting in high morbidity 
of shipped stocker cattle. Moreover, it is well documented that BVDv PI calves have lighter BW 
than BVDv-negative calves of the same age. Therefore, purchasing light body weight cattle might 
represent a risk for acquisition of PI stocker cattle.  
Fulton, et al (2006) indicated that the prevalence of cattle PI with BVDv entering a 
feedlot was also 0.3 percent. BVDv-PI cattle are important sources of virus and shed large 
quantities of virus, thus exposing other cattle in direct or close contact, including pen-mates or 
those in adjacent pens or transportation units. Risk of initial treatment for BRD was 43 percent in 
cattle exposed to a PI calf. In that study, 0.3 percent of cattle entering a feedlot were PI animals, 
2.6 percent of chronically ill cattle were PI, and 2.5 percent of cattle that died were PI. The 
authors of that study reported that 15.9 percent of initial cases of BRD were attributed to 
exposure to PI calves. Although the prevalence of PI cattle entering a feedlot is low, considerable 
disease may develop in exposed cattle. Thus, control of feedlot diseases appears to be aided by 
removal of PI calves, minimizing risks attributable to those calves. The 86 PI calves were held in 
quarantine pens or subsequently remained in the starter yard. Within approximately 60 days after 
processing and arrival, 22 of the 86 PI calves had died; 14 had the mucosal disease, 6 had 




Furthermore, another study researched cattle that were housed in 20 pens of 
approximately 100 cattle each and managed in accordance with routine feedlot practices. During 
initial processing, cattle were evaluated for signs of illness by trained feedlot personnel. When 
cattle suspected of being ill were identified, they were moved to a cattle-handling facility and 
treated according to treatment protocols developed by the consulting veterinarian. Cattle were 
typically deemed to be chronically ill if they failed to respond favorably to the administration of 3 
courses of treatment. These cattle were removed from group 1 and transferred to a separate 
feedlot for convalescent cattle. Cattle that died underwent postmortem evaluation, and cause of 
death was assigned under the supervision of the consulting veterinarian. In the first analysis, 
which evaluated the effect of exposure to a PI animal on morbidity rate, exposure was defined as 
those cattle within a pen that contained a PI animal. Overall, cattle in 4 pens that contained 402 
cattle were considered exposed, whereas cattle in 16 pens that contained 1,598 cattle were 
considered not exposed. The risk of disease in exposed and not exposed cattle was 7.0 percent 
and 5.9 percent, respectively; these were not significantly different (relative risk, 1.17; 95 percent 
CI, 0.74 to 1.69 [P = 0.60]). The incidence of disease in the exposed and not exposed cohorts was 
4.6 and 3.9 treatments 10,000 head-days, respectively (rate ratio, 1.18; 95 percent CI, 0.75 to 1.76 
[P = 0.53]). Pens with exposed cattle were more likely to have cattle with greater than mean risk 
of treatment for respiratory tract disease (P = 0.03); cattle in 7 of the 10 pens with cattle with the 
greatest risk of treatment were exposed to a PI animal, whereas cattle in only 2 of the 10 pens 
with cattle with the lowest risk for treatment were exposed. When incidence rates were compared 
between cohorts, exposed cattle had 48 percent greater (P = 0.03) incidence of initial respiratory 
tract disease, compared with non-exposed cattle (Longeragan, et al. 2005). 
Vaccination and Control  
Based on the NAHMS 2007-08 Beef Cow-calf study, only 12.3 percent of cow-calf 
operations were unfamiliar with BVDv and 64.0 percent of operations knew some basics or were 
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fairly knowledgeable about the virus. These results are likely a reflection of the substantial 
coverage the agriculture media has devoted to BVDv in the past few years. While producers are 
generally aware of BVDv, relatively few (4.2 percent) had done any testing of calves for 
persistent infection with the virus in the past 3 years. Larger operations (200 or more beef cows) 
were much more likely than smaller operations to have tested calves for persistent infection with 
BVDv in the past 3 years (15.6 percent of operations). The low overall rate of testing might 
indicate that most producers do not believe their herd is at risk. Producers might also believe that 
the cost-benefit ratio for controlling the disease is prohibitive. Among the 44,150 ear-notch 
samples collected and tested, only 53 (0.12 percent) were positive for the BVDv antigen (USDA, 
2010). 
The most commonly used tests are the immunohistochemistry test (IHC) done on ear 
notches preserved with formaldehyde and the antigen capture ELISA test (ACE) done on fresh 
ear notches or blood serum. The Kord Animal Disease Diagnostic Lab in Nashville performs the 
ACE test. Recent research has shown this test to be as useful and accurate as the IHC test. The 
test has a quick turnaround time but in certain cases, it should be repeated in 3 weeks to 
distinguish between PI calves and newly infected calves. A good vaccination program that will be 
successful against BVDv should begin at about 6 months of age of the calf. Many good BVDv 
vaccines are available and if used properly can be expected to be a very useful part of BVDv 
control in the cowherd. Vaccination along with biosecurity measures are needed to keep the 
disease out of the herd and the beef industry as a whole. These measures would include 
maintaining a closed herd or buying only from known BVDv free herds. Testing should also 
occur when any new animals are brought into the location and should be isolated from the rest of 
herd for 1 month after arrival as a precaution (Kerr, Hopkins, and Welborn, 2001). 
One study compared the effectiveness of reproductive protection in cattle against bovine 
viral diarrhea virus (BVDv) and bovine herpesvirus 1 (BoHV-1) through the annual revaccination 
19 
 
with multivalent modified-live viral (MLV) vaccine or multivalent combination viral (CV) 
vaccines (Houe, Lindberg, Moennig, 2016).  These vaccines contained temperature-sensitive 
modified-live BoHV-1 and killed BVDv and were given pre-breeding to nulliparous (not 
pregnant/have not had a calf) heifers.  Seventy-five  beef  heifers  were  allocated  into  treatment  
groups  A (n = 30; two MLV doses pre-breeding, annual revaccination with MLV vaccine), B (n 
= 30; two MLV doses pre-breeding, annual revaccination with CV vaccine) and C (n = 15; saline 
in lieu of vaccine). Heifers were administered treatments on days 0 (weaning), 183 (pre-
breeding), 366 (first gestation), and 738 (second gestation). After first calving, primiparous (only 
having one calf thus far) cows were bred, with pregnancy assessment on day 715. At that time, 24 
group A heifers (23 pregnancies), 23 group B heifers (22 pregnancies), and 15 group C heifers 
(15 pregnancies) were commingled with six persistently infected (PI) cattle for 16 days. Ninety-
nine days after PI removal, cows were intravenously inoculated with BoHV-1. All fetuses and 
live offspring were assessed for BVDv and BoHV-1. Abortions occurred in 3/23 group A cows, 
1/22 group B cows, and 11/15 group C cows. Fetal infection with BVDv or BoHV-1 occurred in 
4/23 group A offspring, 0/22 group B offspring, and 15/15 group C offspring. This research 
demonstrates the efficacy of administering two pre-breeding doses of MLV vaccine with annual 
revaccination using CV vaccine to prevent fetal loss due to exposure to BVDv and BoHV-1 
(Walz, et. al. 2017).  
Several European countries have initiated national and regional control and eradication 
campaigns for bovine viral diarrhea virus (BVDv). In European countries without organized 
BVDv control programs, vaccination is still commonly used to control BVDv. Diagnostic test 
strategies are fundamental to all control and eradication campaigns and how the utilization of 
available diagnostic tests are used to maximize efficacy. Laboratory techniques are available for 
BVDv diagnosis at the individual animal level and at the herd level. These are strategically used 
to achieve 3 main objectives: 1) initial tests to classify herd status, 2) follow-up tests to identify 
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individual BVDv-infected animals in infected herds, and 3) continued monitoring to confirm 
BVDv free status. For each objective or phase, the validity of the diagnostic tests depends on the 
mode of BVDv introduction and duration of infection in test-positive herds, and on how long 
non-infected herds have been clear of BVDv (Houe, Lindberg, Moennig, 2016).  
Wittum, et al. (2001) collaborated with 48 different veterinary practices to use as a 
sampling cluster and select herds that were required to have 20-500 head of cattle from each 
frame in the list. This study tested the prevalence of BVDv in beef herds by using a sampling 
throughout different veterinary practices and determining the effect that PI calves had on the herd 
as a whole. Blood samples were taken from the calves before they were 4 months old in each herd 
and sent to Ohio State University for testing. A second sample was taken at 6 months of age from 
the calves that tested positive for BVDv and were reexamined for the type of BVDv that was 
detected. The dams of the infected calves also had samples taken from them to determine the type 
and method of infection. The models that were used were based on production measures. The 
proportion of mature cows pregnant, the proportion of replacement heifers pregnant, the 
proportion of females that calved, the proportion of females that calved early in the season, 
neonatal mortality and postnatal mortality were the measures of production that were calculated. 
The production measures were compared to the herds and number of calves that tested positive 
for BVDv. The results showed that there were 56 BVDv positive calves out of 76 in suspected 
selected herds. At least one herd in every one of the five states was found to be BVDv positive. 
10 out of 13 herds of randomly selected had cattle that tested positive. A second serum was 
obtained at 6 months of age from 43 of the 56 calves that initially tested positive and 33 of the 
initially infected animals then tested positive again so, therefore, they are PI calves. The other 10 
of the 13 that a second sample was not obtained from were reported to be dead before 6 months 
of age. The samples taken from the dam of the 45 initially positive calves revealed that three 
dams on two farms were BVDv positive and were considered PI animals. The study confirmed 
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that 3 percent of randomly selected herds had calves that were infected with BVDv. Moreover, 19 
percent of suspected herds had calves that were infected with BVDv. The presence of multiple PI 
calves in a herd suggests the presence of multiple susceptible females in the herd as well. Herds 
with PI calves had a 5 percent lower pregnancy rate than non-PI infected cattle. Persistently 
infected calves that survive to weaning provide a constant source of the disease to the rest of the 
herd and could result in more PI calves born every year without proper intervention (Wittum, et. 
al, 2001) 
Due to high capital requirements, disease prevention is more important than ever.  The 
first commercial laboratory to offer BVDv-PI testing is Central States Testing. Central States 
Testing (CST) tests about 540,000 head annually. 90 percent of the cattle tested are at a high risk 
of susceptibility because they are from stockers and feedlots where the highest percentage of 
comingling occurs which manifests the disease. The prevalence rate based on the testing of the 
cattle is stagnant at 0.38-0.42 percent every year.  The total cost of BVDv is estimated at $1.9 
billion annually in 2011 (Ishmael, 2013). This is based on a cost of $35-$56 per head. Relatively 
few cattle arrive at feedlots that are PI infected cattle. However, BVDv is a catalyst for the 
common pathogens we deal with because of the immunosuppressive effect of the virus. The 
prevalence of PI infected cattle in this study was 0.3 percent. There is a detrimental impact on 
cattle that are exposed to PI-BVDv cattle due to the immunosuppression that causes multiple 
other diseases to occur. Economically, there is a loss of $93.52 per animal in this case study. The 
largest segment of the loss was in overall performance which amounted to $88.26 per animal 
while the remaining $5.26 per animal was a result of the increase in fatality percentage. The feed 
efficiency of feed conversion is the main factor that is impacted by BVDv. Unexposed cattle 
typically convert 55 percent more efficiently than cattle with direct exposure to BVDv. Heifers 
tend to be the most susceptible to birthing PI calves because of their lack of maturity and lower 
level of basal protection then mature cows.  
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Screening cattle for PI with BVDv prior to introduction to a herd can be accomplished 
through testing of individual skin biopsy specimens by means of IHC staining or through testing 
of pooled blood or serum samples with an RT-PCR assay. The use of pooled samples minimizes 
the expense of screening cattle from herds with a low prevalence of PI, in that all cattle 
represented in pooled samples for which assay results are negative are themselves considered to 
be negative for BVDv infection. However, pooled samples for which results are positive come 
from a mixture of cattle with PI, transiently infected cattle, and uninfected cattle, and 
confirmatory tests, such as IHC staining, must be performed on all animals represented in the 
pooled sample to identify animals with PI (Larson, et. al. 2005). 
A simulation model for determining the economically optimum sample size in 
populations with a various prevalence of PI has been developed. As prevalence decreases, the 
least-cost initial pool size increases. The purpose of this study was to develop partial budgets to 
compare the economic costs of 2 test strategies for screening cattle for PI with BVDv. The test 
strategies that were evaluated included a single-test strategy, which consisted of IHC staining of 
skin biopsy specimens from all animals, and a 2-test strategy, which consisted of RT-PCR of 
pooled blood samples followed by IHC staining of skin biopsy specimens from animals in pools 
for which results were positive. The prevalence of PI with BVDv in feeder cattle was varied from 
0.1 percent to 1.1 percent in intervals of 0.2 percentage points, the cost of a single IHC test was 
varied from $6 to $16 in $2 increments, and the cost of RT-PCR assaying of a single pooled 
blood sample was varied from $1.50 to $3.50 in $1 increments. The profit per calf and cost of 
feeder calves were fixed at $25 and $600, respectively. The cost of whole-herd diagnostic testing 
of feeder cattle for PI with BVDv was considered to be the sum of the costs associated with true-
negative, false-positive, and false negative test results. The cost of true-negative test results was 
the cost of testing each calf negative for PI with BVDV and was calculated with the following 
formula: cost of true-negative test results = (1 – prevalence) X test specificity X test cost. 
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Because the most likely response to a positive test result is immediate euthanasia, the cost of 
false-positive test results was calculated from the cost of testing, the purchase price of the animal, 
and the forfeited profit of the animal with the following formula: cost of false-positive test results 
= (1 – prevalence) X (1 – test specificity) X (animal cost + test cost + forfeited profit). The cost of 
false-negative test results is largely the cost of the disease and was calculated with the following 
formula: the cost of false-negative test results = (prevalence X [1 – test sensitivity]) X (cost of PI 
with BVDv per animal + test cost). To justify a testing strategy, the cost of true-positive test 
results must exceed the combined cost of true-negative, false positive, and false negative test 
results. The cost of true-positive test results is largely influenced by the negative cost of feeder 
calves with PI for a feedlot or stocker operation and was calculated with the following formula: 
cost of true-positive test results = (prevalence X test sensitivity) X (cost of PI with BVDV per 
animal – test cost). In the present study, we found that if the prevalence of disease was low, the 
cost of PI with BVDV would need to be quite high when using the single-test strategy, even if the 
testing cost (ie, costs associated with animal handling, sample collection and submission, and 
laboratory testing and interpretation) was low ($6/test). As prevalence increased, the economic 
cost of PI with BVDv was necessary to justify this testing strategy decreased because the costs of 
screening were spread over more true-positive cattle (Larson, et. al. 2005). 
 
Summary 
BVDv is a contagious disease that can cost producers thousands of dollars. This disease 
is not always identifiable, is contagious and detrimental to herds that are susceptible. The cost of 
whole herd screening is not economically feasible for producers because the likelihood of being 
infected seems to be small enough that producers are not willing to assume the cost of testing.  
However, testing and controlling the disease has merit and should be considered to bridge the gap 











BVDv IN THE BEEF INDUSTRY 
 
The beef industry is very complex for a variety of reasons (Peel, 2018 ‘A’). The industry 
consists of multiple production subsections including geographically dispersed cow-calf 
production; more concentrated stocker operations and highly concentrated feedlot finishing 
operations. These subsectors are connected by extensive animal transportation and commingling 
activities. One unique aspect of the industry is how cattle are moved and handled from weaning 
to the feedlots. There is not a direct path that every animal goes down which makes tracking and 
evaluating the movements of a single animal difficult. Each individual animal comes into contact 
with hundreds or thousands of other animals throughout their lifespan. BVDv is a unique 
challenge because PI cattle provide a continuous source reservoir of disease exposure. When 
incorporating a disease that is shed through individual contact, that amplifies the ability to spread 
the disease. Figure 1.0 provides a schematic example of how the virus starts at the cow-calf level 
and transfers all the way through to a feedlot operation and all of the different outcomes of the 
disease.  
 A  PI calf results when the host cow or heifer is infected during the first trimester of the 
pregnancy. Non-infected cows will produce a healthy calf. However, infected cows will either 
abort the calf or give birth to a Persistently Infected (PI) calf. Increased abortion rates result in 
decreased calving percentage. If a cow aborts early, there is a reduced possibility of her 
rebreeding; however, late breeding means that the weaning weight of the calf and the average 




herd culling. If the cow gives birth to a PI calf, the cycle of industry impacts begin. The calf 
exposes every other animal in the operation and compromises the immune systems of all the 
cattle and calves in the herd for as long as it remains in the herd. The calf will also expose any 
animals along the fence lines of the operation, including neighboring herds. The PI calf might die 
at this stage or it might survive. If it survives the calf could either be reintroduced into the herd as 
a replacement heifer or taken to auction, or be sold to a stocker/feedlot operation. If it is 
reintroduced into the operation, the PI heifer will continually give birth to PI calves and the cycle 
will continue in the cow-calf operation.  
 Once a PI calf is brought to auction, it immediately exposes all other cattle to BVDv at 
the auction. It also exposes all of the cattle that it came into contact with through the 
transportation process. Each incidence of exposure increases the chance of morbidity and 
mortality. The PI calf may die or be sold to a stocker operation.  
 Whether the PI calf came to the stocker from an auction or a direct transaction from a 
cow-calf producer, the cycle follows a similar path. The PI calf comingles with the pens of cattle 
it comes into direct contact with as well as adjacent pens. The PI calf has a high probability of 
mortality. If it survives, it typically has higher morbidity and it will not gain weight as efficiently 
which will take longer to reach a desirable weight to sell. The calf will also infect other calves 
which increases the chance of morbidity and mortality of exposed cattle. This increases the 
overall treatment costs for the operator.  
 If the calf survives the stocker stage it is either sold directly to a feedlot operation or 
taken back to auction. At the feedlot, the PI calf comingles with the pens of cattle it comes into 
direct contact with as well as adjacent pens. The PI calf has a high likelihood of mortality. This 




reduced performance with lower average daily gain and reduced feed efficiency. This will lead to 




Figure 1. BVDv Transmission through Beef Sectors 
 
 
BVDv through the Beef Industry 
Since PI cattle originate at the cow-calf level, eradication or control at this stage is the 




commingling with non-infected animals begins and spreads throughout the beef industry. PI 
animals are created in the first trimester of gestation. When the calf is born, it begins shedding the 
disease through the herd as well as through any fence line contact on the operation.   This 
decreases calving and weaning weight percentages. The immunosuppression that the disease 
causes acts as an agent in exploiting weaknesses in the immune system that then makes the 
animal susceptible to any disease which it comes into contact.  
Though BVDv incidence is relatively low, the unique characteristics of the disease 
greatly amplify the exposure and impacts of the disease across the industry. For example, the 
2017 U.S. calf crop was 35,808,000 with an incidence rate of 0.3 percent, implying that 
10,742,400 head were PI calves (USDA NASS). Studies show that approximately 79 percent of 
feedlot cattle are exposed to BVDv (Larson, 2015).  
The largest effect of the disease has been implicated in the environments with the largest 
percentage of commingling. However, control of PI is challenging at the stocker and feedlot 
operations. PI calves having already exposed surrounding cattle with BVDv, control is less 
effective. Even when isolating infected animals, cattle that come into contact with the PI animal 
have already been exposed and are infected by the disease. Consequently, the damage is started 
and on a rampage by the time the infected animals leave the cow-calf operation. Therefore the 
key to BVDv disease control is prevention of BVDv-PI animals from spreading BVDv by 











There are multiple types of market failure. Market failure occurs in a situation in which 
the allocation of goods and services is not considered efficient, leading to a net social welfare 
loss. Market failures can be viewed as scenarios where externalities prevent the optimal allocation 
of goods or services. Externalities are when the gains or losses associated with the product, 
production or consumption of a product, differ from the private cost or benefit to the individual. 
These externalities can be innate to the methods of production or other conditions important to 
the market (Bator, 1958).  
 
Market Failure in BVDv Control 
Determining the economic impact of Bovine Viral Diarrhea in the beef industry and the 
economic feasibility of eradication of the disease at the cow-calf level is necessary to determine if 
better control of the disease is cost-effective to the beef industry as a whole. The economic 
impact caused by Bovine Viral Diarrhea has not been fully assessed and is costing producers 
thousands of dollars which could be alleviated through enhanced control (Ishmael, 2013). There 
is market failure when the current level of BVDv control is less than optimal for the entire 
industry. The largest impacts of the disease are seen at the stocker and feedlot levels where the 
highest percentage of comingling occurs thus translating into a negative externality due to 




effective method of controlling and preventing the disease remains at the cow-calf level through 
vaccination and eradication of PI animals (USDA APHIS, 2007).  
The disease is transferred through bodily fluids, meaning any animal that is infected that 
encounters or sheds the virus through fluids will infect other animals. This affects the market 
because throughout every sector animals are exposed, and this will cost every level of the 
industry. However, often those costs are not fully recognized. The industry view of the disease 
implications is different than the views from each individual sector. The disconnect that occurs 
between the sectors is due to lack of recognition of the costs associated with the disease on every 
level. In an infected herd, a cow-calf producer will have lower calving and weaning percentages 
as well as increased treatment costs. Because the disease often shows up as an acute infection 
with obscure symptoms, the impacts are overlooked (Ridpath, 2010 ‘A’). Stocker and feedlot 
operations will have increased death loss as well as increased treatment costs and lower 
productivity. All of these factors increase production costs. Yet while BRD is widely recognized 
as a major hindrance in stocker and feedlot operations, the role of BVDv in the disease impact is 
not recognized. If the costs are fully recognized on every level of the beef industry, there could be 
a movement to close the gap in which the market failure manifests and result in an industry 
optimal level of BVDv control. 
The incidence rates are at the highest in the cow-calf level of the industry. Conceptually, 
the question leading this research is identifying the optimum level of disease control. The direct 
costs of BVDv infection are losses from reproductive disease, from the poor performance of the 
PI animals, and the increased disease impacts of exposed animals. A component of this loss is 
directly related to the increased mortality and morbidity of PI animals. This is particularly 
significant in feedlots. Indirect costs such as decreased production, poor growth and increased 
incidence of other diseases also have large associated costs. Due to the complex nature of the 




economic losses caused by BVDv infection give estimates based on calculated assumptions and 
most are likely to underestimate the indirect costs. These indirect costs are associated with 
production losses incurred by the producer and have not been fully evaluated. Nonetheless, cost 
estimates for both, endemic (ongoing), and epidemic (outbreak) BVDv infection exist and are 
used to determine what incentive is necessary to entice producers to implement vaccination 
programs and eradicate PI animals. 
Market failure occurs because when evaluating disease control as a good, the total social 
costs, i.e. industry costs, are higher than the primary costs in each section. The cost of the disease 
is only assumed by producers to be in the morbidity and mortality costs of infected sick BVDv-PI 
cattle. The incidence rate in infected herds is low and the prevalence rate of herds across the 
United States is low, therefore most producers rely on the high probability that their herd is not 
infected. However, the negative externality of this disease that cause it to be a market failure is 
not derived from the sick cattle individually, but from their ability to shed the disease broadly and 
expose multiple animals in which they come into contact. A single PI calf has the capacity to shed 
the virus to 79 percent of the herd (USDA, 2010), meaning that 79 percent of the herd has been 
immunosuppressed and more susceptible to a variety of diseases that cause increased morbidity 
and mortality percentages. This is an indirect effect of the disease, yet it causes a direct loss to the 
producer and impacts profitability of the herd.  
The incidence and infection rate of BVDv-PI cattle throughout the United States is 
relatively low. Approximately 4 percent of herds across the United States having at least one or 
more PI animals in their herds and the incidence rate within the herd being approximately 0.3 
percent, the disease’s severity is underestimated (See Chapter 2). From the 2012 Census of 
Agriculture report, the total number of beef farms that contained cows and heifers that calved was 
727,906 (USDA NASS, 2012). The number of cattle within those farms is 29,730,518. Therefore, 




with 89,191 infected animals. Therefore on average, there are approximately 3.06 infected 
animals per infected farm across the United States. These infected animals have the ability to 
commingle and come into contact with multiple locations exposing a multitude of animals, 













METHODOLOGY AND DATA 
 The total cost of BVDv to each sector the beef industry is not completely recognized by 
producers. Therefore, the benefits of a vaccination and eradication program are also not fully 
recognized in any sectors of the beef industry. A partial budget is an appropriate tool to outline 
the costs and benefits of a BVDv control program and can be implemented across involved beef 
industry sectors. Partial budgeting is a tool that is used to determine how a change in one part of 
an operation would impact an operation’s returns. This is used instead of a full enterprise budget 
since the change would only be implemented in few areas of the operation versus across the entire 
operation. A partial budget only includes resources that will be changed, and it does not consider 
the resources in the business that are left unchanged. Only the change under consideration is 
evaluated for its ability to increase or decrease income in the operation. There are four 
components in the base budget that detail how changing or implementing a factor into an 
operation would change it. The main components of a partial budgeting tool are additional cost, 
reduced revenue, additional revenue and reduced cost.   This can be accomplished at a herd and 
single operation basis and then applied to an aggregate level.  
Simulated Herd Profile:  
 To determine the economic cost of BVDv at the cow-calf level, a partial budgeting tool 
was used to incorporate all the necessary costs and benefits of an enhanced control program. The 




vaccination program. The comparison of budgets illustrate multiple changes to each of the four 
sections in the partial budgets evaluating costs and benefits of implementing an enhanced control 
program for the operations. 
 In this case, a base budget was created for a cow-calf operation that was not infected. 
This operation implements a testing and a vaccination program into their protocol. Another partial 
budget was created for an infected cow-calf operation, a stocker operation that tests for BVDv, a 
non-testing stocker operation, a testing feedlot operation and a non-testing feedlot operation. A 
second-year budget shows that the initial cost of enhanced control lowers after the initial 
eradication of the infected animals. These budgets were compared to the base budget for 
effectiveness to determine what the monetary incentive or disincentive would have to be to 
encourage producers to implement an enhanced BVDv control program.  
Figure 2. Budget Analysis Connection 
 
 A base herd profile was designed with assumptions to determine the cost of 
implementing the control program budget throughout the industry. This study simulates 1000 




United States is roughly 50 head of cows and 100 animals in total. This is used as a starting point. 
The national average calf crop percentage calculated from annual cattle inventory and calf crop 
numbers is about 88 percent in the last decade (USDA-NASS).  Taking out the dairy sector, the 
beef calf crop is estimated to be 85 percent (Peel, 2018 ‘B’). Since tha national beef calf crop 
average is approximately 85 percent this results in about 42.5 calves per 50 cows on average in 
the simulation. Since the disease does not discriminate based on the sex of calves, the percentage 
of infection will be distributed across both steers and heifers. This accounts for 92.5 of the 
animals in the herd. The remaining 7.5 animals in the herd are assumed to be replacement heifers 
and bulls for the operation. The total number of animals for the simulation amounts to 100 head 
per herd. Therefore, the total inventory from all 1000 herds will be 100,000 head (Table 1). 
Table 1. Herd Profile 
Herd Percent of Herd % of Population Total Total Cost Per Cow Cost 
Herds   1000   
Head per Herd  100.0% 100   
Cows  50.0% 50   
Calves 85% 42.5% 42.5   
 Heifers 50% 21.3% 21.25   
 Steers 50% 21.3% 21.25   
Other  7.5% 7.5   
Total Head   100000   
Herd Infection Rate 4%     
Infected Herds   40   
Incidence In Herds 0.3%     
Infected Animals   300   
Infected Animals Per Herd   7.5   
Per Head Infection   0.075   
Cows/Other Prevalence  15.0%  1.125 $1,127.25 $22.55 
Calves Prevalence 85.0%  6.375   
    Steer Prevalence 42.5%  3.1875 $2,663.63 $53.27 
    Heifer Prevalence 42.5%  3.1875 $2,308.64 $46.17 
 Total Calf Cost     $99.45 
Per Cow Total      $121.99 
 
Table 1 Herd Profile     
Herd Percent of Herd 
% of 




Herds   1000 
Head per Herd  100.0% 100 
Cows  50.0% 50 
Calves 85% 42.5% 42.5 
 Heifers 50% 21.3% 21.25 
 Steers 50% 21.3% 21.25 
Other  7.5% 7.5 
Total Head   100000 
Herd Infection Rate 4%    
Infected Herds   40 
Incidence In Herds 0.3%    
Infected Animals   300 
Infected Animals Per Herd   7.5 
Per Head Infection   0.075 
Cows/Other Prevalence  15.0%  1.125  $                     1,127.25 
Calves Prevalence 85.0%  6.375 
    Steer Prevalence 42.5%  3.1875  $                     2,663.63 
    Heifer Prevalence 42.5%  3.1875  $                     2,308.64 
 Total Calf Cost         
Per Cow Total      
The prevalence rate among herds throughout the United States ranges from 3 percent -5 
percent resulting in one or more PI animals within an infected herd (USDA APHIS, 2007).  For 
this analysis, the average herd prevalence rate of 4 percent was utilized across the 1000 herds 
resulting in 40 infected herds. The incidence rate of cattle across U.S. beef herds is 0.3 percent. 
Meaning that 0.3 percent of all cattle in the United States are infected with BVDv (USDA 
APHIS, 2007). This prevalence was applied to the total number of animals in all of the herds 
resulting in 300 animals out of 100,000 being PI animals. Since the infected animals are only 
within the infected herds, they were averaged across the 40 herds that had PI animals. Each 
infected herd contains 7.5 PI animals on average. The prevalence rate throughout the herd will be 
higher in the calves versus the cows and other animals due to the fact that they are the most 
susceptible and are more likely to be PI animals. It was estimated that 15 percent of the 
prevalence is attributed to the cows and other animals while 85 percent of the prevalence is 
attributed to the calves (USDA APHIS, 2007). This allocation of disease prevalence is associated 
with the higher percentage of incidence being in calves versus mature animals. Infected animals 




heifers equally. Therefore the calf prevalence is split equally to accommodate for the price 
difference between steers and heifers. Therefore, they were divided into three categories: 
cows/other, steers and heifers. This means that 1.125 of the PI infected animals are cows/other 
animals and the other 6.375 infected animals are calves which are split 50/50 between the genders 
(Table 1).  
Costs and benefits applied in the budgets are based on data and previous literature. On 
average, with the eradication of infected animals and the vaccination to boost immune systems, 
calving percentage in a BVDv-free herd is approximately 2 percent higher than an infected herd. 
Weaning weight is also increased by 2 percent compared to an infected herd (USDA APHIS, 
2007). Morbidity treatment is estimated to be at $0.11 on a per cow basis in a typical operation 
that does not have any known infection issues (NAHMS 2010). The morbidity incidence 
throughout cows and calves in a typical herd that does not have any BVDv incidence is estimated 
to be about 3 percent, while a herd that has of BVDv-PI incidence is estimated to have 15 percent 
morbidity (USDA APHIS, 2007). Typical treatments are done twice on mild cases of morbidity, 
while major cases average 3 treatments per animal. The cost of treatment is determined through 
the cost of vaccinations on a per animal basis for the most common problems in herd health and 
in particular, using antibiotics to treat sick animals (Table 2). 
 
Table 2. Infected Herd Differences from Non-Infected 
Infected Herd      











Calving percentage -2% 83.33% 41.67   
   Steers -1% 41.67% 20.83 $348.188 $6.96 
   Heifers -1% 41.67% 20.83 $301.783 $6.04 
 Total     $13.00 
Increased Weaning 
Weight      
   Steers -3.0% 485.44 14.56 $24.34 $0.49 




Total     $0.91 
 
 Testing cost is based on information from Central States Testing (CST)1. The pooled 
testing which can have pools of 10 head which costs $6.50 per pool. Individual testing is $2.50 
per head. If a positive result is found in a pooled test, then each animal must be tested 
individually to find the infected animal. To determine the pools, we assumed that mature cattle 
and calves were tested separately. From a management standpoint, a producer would try to 
minimize the number of animals in each pool so if individual testing is required in that pool then 
there are fewer animals to apply the second cost to. There is a maximum of 10 animals in a pool 
that is tested. However, if there is an infected animal in a pool, a producer will have to do an 
individual test on every single animal in the pool to determine the infected individual. Individual 
tests are $2.50 per head. Since there are 57.5 mature animals in a herd, it would require an 
average of 5.75 pools required to cover all of the animals. To smooth this average out, we 
assumed 6 pools. For calves, the average number of pools required for 42.5 animals is 4.25, once 
smoothed out we assumed 5 pools. If second round testing should be necessary, reducing the 
animals in each pool is logical so the individual costs would be applied to fewer animals in each 
pool. For mature animals, 57.5 animals were divided by 5 pools which is 9.58 animals a pool. 
This rounded to only use whole numbers amounted to 9 animals in 2 pools and 10 animals in 4 
pools. For calves, there was an average of 8.5 animals in each pool. Once rounded to whole 
numbers amounted to 8 animals in 2 pools and 9 animals in 3 pools (Table 3).    
 Table 3 shows what the best and worst-case scenarios would be on the testing cost 
because infected cattle were determined through the pools. The individual testing would only be 
done on the pools of animals that tested positive instead of the entire herd. Seeing as the pools 
can have up to 10 animals, thus for this study the testing was assumed on the maximum incidence 
                                                           




rate in each category. The maximum amount of individual testing that would be required in a 
BVDv positive herd was $156.25 and the minimum cost was $42.50 (Table 3). The maximum 
total cost of testing which is pooled and then individual for an entire herd was $227.75 and the 
minimum cost was $114.00 (Table 3).  The average cost of the minimum and maximum was 
$170.875 for a herd or $3.42 per cow (Table 3). It is assumed that the second round of individual 
testing will cost $1.00 per cow for additional labor and handling. Tagging animals to identify 
during testing could also be an additional expense. An important factor in implementing this 
control program is that the cost of testing for PI cattle is a one-time cost to the herd. Once it is 
determined that BVDv-PI animals are not present, the only testing that needs to occur afterward is 









Mature Animals in 
Pool 
Calves in 
Pool   
Mature Animal Average 5.75 9.58    
Mature Animal Actual 6     
Calves Average 4.25  8.5   
Calves Actual 5     
Pool Animal 
Distribution      
Pool 1  9 8   
Pool 2  9 8   
Pool 3  10 9   
Pool 4  10 9   
Pool 5  10 9   
Pool 6  10    
Total  58 43   
CST Testing per Head Cost # in Pool Individual Total  
 Pooled $6.50 10 $0.65 $65.00  
 Individual $2.50 1 $2.50   
Pooled Testing Cows/Other Calves    
 # of Animals  57.5 42.5    
# Pools Capacity 6 5    
Incidence 1.125 6.375    
 Min # of Pools  1 1    
Max # of Pools 2 5    
Min # Cattle 9 8    
Max # Cattle  20 42.5    
Cost of Individual 
Testing Test Minimum Per Cow 
Maximu
m Per Cow 
 Cows/Other $2.50 $22.50 $0.45 $50.00 $1.00 
 Calves $2.50 $20.00 $0.40 $106.25 $2.13 
Total  $42.50 $0.85 $156.25 $3.13 
Average $1.99     
Total Cost of Testing Test Cost # Tested Min # Tested Max Cost Min 
Cost 
Max 
 Pooled $6.50 11 11 $71.50 $71.50 
 Individual $2.50 17 62.5 $42.50 $156.25 
Total    $114.00 $227.75 
Average $170.875     







 The only reoccurring cost to a cow-calf operation on a yearly basis would be a 
vaccination program. The vaccination cost is based on a vaccination containing IBR, BVD Types 
I and II, PI3 and BRSV for cows that are 50 doses a bottle with a current cost of $3.84 per head. 
The vaccine for calves contains IBR, BVD Types I and II, PI3, BRSV, Vibrio, 5 strains of Lepto, 
and is $1.27 per head or $2.54 including a second booster shot. Cows are vaccinated during 
pregnancy testing. Calves are vaccinated twice. Once when they are processed for branding and 
an additional booster shot is administered when they are weaned (Table 4). 
Table 4. Vaccination 
 Bovi-Shield Gold 
Vaccination    Cost per Bottle Doses per Bottle Individual Costs Booster Shot Cost 
Calves  IBR, BVD Types I and 
II, PI3 and BRSV $63.39 50 $1.27 $2.54 
Cows  IBR, BVD Types I and 
II, PI3, BRSV, Vibrio, 
and 5 strains of Lepto. $191.99 50 $3.84  
 
 To assess the value of the infected and uninfected animals, calf price data from the 
Oklahoma Weighted Average Cattle Summary was used to determine the price of 500-pound 
steers and 475-pound heifers. These prices were averaged over the last ten years (USDA AMS 
794 KO_LS794). The value of bred cows followed Mitchell et al. (2017) and assumed culled PI 
cows are black, medium framed, four-year old females. The cost of eradicating the infected cows 
within the herd totaled $22.55 on a per cow basis (Tables 1, 5).  
Table 5. Calf, Feeder and Bred Cow Values 
10 Year Weighted OK Auction Prices Per CWT Per Head 
475lb Heifers $152.48 $724.28 
500lb Steers $167.13 $835.65 
875lb Heifers $123.01 $1,076.34 
900lb Steers $132.00 $1,188.00 
Bred Cow Price Determinate  Per Head 





 Morbidity and mortality incidence for the budget assumptions are based on previous 
incidence rates throughout feedlots. On average, death-loss across all cattle in feedlots is 
calculated as 1.43 percent (USDA AMS, 2007 - 2017). The Quarterly Cattle on Feed was used to 
determine what the percentage of heifers were in feedlots compared to steers.  The percentage of 
death-loss that is attributed to heifers is 0.359582. The actual death-loss percentage used for a 
feedlot operation in this study is Kansas State University feedlot death-loss data (KSU Focus on 
Feedlots). The average from the past five years was 1.43 percent using a weighted average 
between steers and heifers in feedlots (USDA AMS, 2007 - 2017). The percentage attributed to 
heifers was applied to the heifer death loss and the remaining percentage was attributed to steers. 
This was necessary to determine the different prices attributed between the genders. On average 
54 percent of feedlot total death-loss is attributed to Bovine Respiratory Disease (BRD) in which 
BVDv is the main immunosuppressive agent or 85 percent of the disease (USDA APHIS, 2001). 
For this budget, 85 percent of the 54 percent of the total death loss was assumed for the death-loss 
caused by BVDv. Therefore 45.9 percent of the total death-loss in an operation is attributed to 
BVDv (Table 6). 
Table 6. Mortality 
Mortality Feedlot Percent Total Total Percent Heifers Heifer Death-loss Steer Death-loss 
Cattle Death Total 1.43%  35.96% 0.236% 0.420% 
 BRD Related  54.0%     
 BVDv attributed 45.9% 0.66%    
Mortality Commercial Stocker  Percent Total Total Percent Heifers Heifer Death-loss Steer Death-loss 
Cattle Death Total 2.46%  35.96% 0.406% 0.723% 
 BRD Related 54.0%     
 BVDv Attributed 45.9% 1.13%    
Mortality Retained Stocker  Percent Total Total Percent Heifers Heifer Death-loss Steer Death-loss 
Cattle Death Total 1.00%  35.96% 0.165% 0.294% 
 BRD Related 54.0%     





 In feedlot and stocker operations, the cost of treatment for morbidity is broken up into 
three sections. Typically, cattle in a stocker or feedlot operation are automatically vaccinated 
upon arrival. Cattle that arrive and appear to be sick are vaccinated and medicated upon arrival 
(USDA APHIS, 2001). Typically, cattle diagnosed with a respiratory disease are treated up to 
three times in an operation with a variety of treatment combinations. The assumption in the 
feedlot budget focused on respiratory diseases in feedlot operations with an incidence rate of 15 
percent across all cattle in the operation (USDA APHIS, 2001). The incidence rate used for a 
stocker operation was approximately 16.02 percent (Peel, D.S., 2018 ‘B’). The most common 
protocol for 93 percent of operations is oral and injectable antimicrobials coupled with 
vaccination upon arrival to prevent any further disease which was valued at $4.00 per head. This 
cost included vitamin B injection, an antihistamine, and a respiratory vaccine (USDA APHIS, 
2013); (USDA NASS, 2012). The cost of the various treatments is an average of the most 
common applications of medicine such as an injectable antimicrobial used with a corticosteroid, 
non-steroidal anti-inflammatory drug, an antihistamine, and a probiotic paste along with 
antibiotics. The medications typically include tilmicosin, florfenicol, and tetracycline (USDA 
APHIS 2001, 2013) the cost on a per-head, per treatment basis was approximately $8.80 on a 
feeder animal and $6.80 on a stocker animal. The cost difference is based on dosages assigned to 
different weights of cattle. This cost multiplied by the average number of treatments totaled at 
$26.40 per animal treated on a feedlot and $20.40 per animal in a stocker operation (Table 7, 8).  
Pendell et. al. (2017) found that incidence of chronic cattle valued at 0.69 percent and these are 
used as the assumption for chronic cattle in this study (Table 9). The price received for chronic 








Table 7. Morbidity Incidence 
Morbidity Incidence Non-Infected Percent Attributed # of Animals 
 Cows/Other 3.0% 1.725 
 Calves 3.0% 1.275 
Morbidity Incidence Infected   
 Cows/Other 15.0% 8.625 
 Calves 15.0% 6.375 
 
Table 8. Morbidity Treatment 
Cow-Calf Total Cost # of Doses Individual Costs 
# of Treatments per 
Animal 
Total Cost Per 
Animal 
Non-Infected 3%      
 Cows/Other 
Penicillin $27.49 30 $0.92 1 $0.92 
 Calves Liquamycin $23.49 25 $0.94 1 $0.94 
Infected 15%      
 Cows/Other 
Penicillin $27.49 30 $0.92 4 $3.67 
 Calves Liquamycin $23.49 25 $0.94 4 $3.76 







Total Treatment Cost 
Per Animal   
 Vaccination $4.00 1 $4.00   
 Oral Antimicrobials $4.40 3 $13.20   
 Injectable 
Antimicrobials $4.40 3 $13.20   
Individual Treatment 
Per head $8.80     
 Total Treatment 
Cost    $26.40   







Total Treatment Cost 
Per Animal   
 Vaccination $3.00 1 $3.00   
 Oral Antimicrobials $3.40 3 $10.20   
 Injectable 
Antimicrobials $3.40 3 $10.20   
Individual Treatment 
Per head $6.80     
Total Treatment 




















 First Treatment 0.44% 85% 0.59%   
 Second 
Treatment 0.17%     
 Third Treatment 0.08%     
Total 0.69%     
Cost of Chronic    $0.25 $212.50 
 
 To determine the value of death-loss caused by the infected animals in feedlot operations, 
price data of the Oklahoma Weighted Average Cattle Summary was used to determine the value 
of 900-pound steers and 875-pound heifers, averaged over the last ten years (USDA AMS 794 
KO_LS794). The average cost of death-loss to the operations totaled $7.53 on a per head basis 
(Table 5). In a stocker operation, the value of death loss was determined using the price data of 
the Oklahoma Weighted Average Cattle Summary for 500-pound steers and 475-pound heifers 
averaged over the last ten years (USDA AMS 794 KO_LS794). 
 A large cost that is associated with feedlot operations is the production loss that is caused 
by BVDv infection. The immunosuppression that the disease inflicts on susceptible cattle is a 
large factor in the costs associated with production losses. On average, BVDv-PI animals shed the 
disease, exposing up to 79 percent of surrounding animals in an operation (Larson, 2015). 
Estimates of the cost of production losses for an operation varies across multiple sources. In Peck 
(2006) BRD accounts for approximately 70 percent of feedlot morbidity and 50 percent of feedlot 
mortality, negatively affecting profit. This study provides an economic evaluation and net return 
estimate associated with testing and removal of BVDv- PI calves of differing management 




Auction market (AM) calves gained 1.87 pounds per day and preconditioned (PC) calves gained 
2.65 pounds per day for 42-day trial. Morbidity rate AM was 70 percent and PC is 6.7 percent 
(Vestal and Richeson, 2014). Whereas another study estimated that there was a cost of $47.00 per 
head of all animals that entered a feedlot (Peck, 2006). In feed yards, BVDv can cost $31-$41 per 
infected head (Brooks, et. al. 2011). Therefore when a 10,000 head feedlot was tested and a 0.4 
percent prevalence was detected along with 72 percent of the pens being exposed to the disease, 
the overall observed cost per head was $47.92 across all animals (Animal Health, 2016).  This 
resulted in total cost to the feedlot of $479,200 compared to testing costs of $35,000 (Animal 
Health, 2016). By exposing a general population of cattle to BVDv-PI infected animals, the 
performance losses vary along with the prevalence rate. The feedlot cattle in one study attributed 
costs of $67.49 per head across all animals due to performance losses and fatality.  It was 
estimated that the performance losses valued at $58.83 while the remaining cost per animal is 
attributed to mortality (Larson et. al., 2005). On a more detailed study, the estimated costs of 
BVDv were approximately $93.52 per calf which include cattle that were exposed to the disease 
and infected cattle. The performance losses were estimated at $88.26 per animal and mortality at 
$5.26 per animal (Ishmael, 2013) (Table 10). When estimating production losses across all 
animals in a feedlot, which included infected cattle and cattle exposed to PI animals, the range 
was estimated to be $47.92-$58.83. The average of this range is $53.38 and this was the 
assumption utilized in the stocker budget. The number will be applied to all cattle that come into 
contact with the disease in an operation which was assumed at 79 percent of an operation.  














Gain(kg) 34 38 42 48 50 $47.92 
ADG(kg) 0.55 0.59 0.68 0.73 0.74 $58.83 
f/g (kg) 18.88 9.47 7.27 6.57 6.78 $53.38 
COG ($/kg) 6.31 3.09 2.25 2.01 2.09  




Chronic (%) 4.6% 5.0% 3.6% 2.7% 2.8%  
Dead (%) 3.6% 3.5% 2.4% 1.3% 1.7%  
Average 
Treatment # 1.79 1.77 1.72 1.58 1.66  
(Ishmael, 2013) 
 
 In the herd simulation, there are 1000 herds at the beginning, based on feedlot data used 
by Stehle (2017), it was determined that 30.8 percent of operations retain their stocker cattle and 
then sell them directly to a feedlot operation (Stehle, A.M., 2016). The cattle numbers that are 
used for the stocker simulation are determined by the number of calves that are born in cow-calf 
operations. Both in infected and non-infected herds. The assumption is that the prevalence rate is 
the same across retained and commercial stocker operations, yet the performance of infected 
retained stocker operations is like the performance of commercial operations. The incidence rate 
is applied to the retained stocker operations to determine how many operations would have 
infected cattle. Animals from infected retained stocker operations are then subtracted from total 
animals in retained operations and moved to commercial operations to account for the losses 
associated with the disease while the retained stockers are isolated and do not come into contact 
with the disease, therefore, the damage is significantly less. 
Non-Infected Herd Partial Budget 
 In the non-infected cow-calf herd base budget, it was assumed that the herd tests for 
BVDv with zero positive test results. However, the operation still implemented a vaccination 
program to enhance biosecurity measures within the herd. In the additional cost portion of the 
budget, the operation added in testing for the herd, vaccination of the cows on a yearly basis and 
the vaccination of each calf crop twice. The additional cost includes the assumption that the first 
set of testing and vaccination will have minimal labor costs due to the processing that will already 




have any addition to the base budget. The reduced cost portion takes into account the fact that 
vaccination against immunosuppression of BVDv will increase the herd's overall ability to fight 
infection. This, in turn, reduces the cost of morbidity across the herd. (Table 11).  
 
Table 11. Non-Infected Cow-Calf Partial Budget (Total Head 48,000) 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Cow Additional Revenue Head $/Head Total $ $/Cow 
Initial Testing          
 Pooled Testing 11 $6.50 $71.50 $1.43      
          
Vaccination          
 Cows 50 $3.84 $191.99 $3.84      
 Other 7.5 $3.84 $28.80 $0.58      
 Calves x 2 42.5 $2.54 $107.76 $2.16      
Total    $8.00 Total    $              - 
Reduced Revenue  Head $/Head Total $ $/Cow Reduced Cost Head $/Head Total $ $/Cow 
     
Morbidity 
Treatment     
     Cows/Other 
1.72
5 $   0.92 $  1.58 $0.03 
     Calves 
1.27
5 $   0.94 $  1.20 $0.02 
           
Total    $        - Total    $0.06 
Total Negative 
Effects    $8.00 Total Positive Effects    $0.06 
     Net Gain or Loss Per Cow   $(7.95) 
     Aggregate    $(381,381.92) 
 
 The second year of the non-infected cow-calf operation is similar but with less testing. 
Testing would only be necessary if the operation introduced any new cattle into the herd. 
Assuming that the operation doesn’t introduce any new animals indicates that the only additional 
cost will be the reoccurring vaccinations required each year including one shot for a bred cow 
during pregnancy to prevent a PI calf infection, and the two vaccinations for calves, one at 




continuing a vaccination program, the morbidity costs will be lower and any still included in the 




Table 12. Non-Infected Cow-Calf Partial Budget Year 2 
Negative Effects:         Positive effects:     
Additional Cost  Head $/Head Total $ $/Cow 
Additional 
Revenue Head $/Head Total $ $/Cow 
Initial Testing          
New Cattle* 0 $0.65 $ - $ -      
          
Vaccination          
 Cows 50 $3.84 $191.99 $3.84      
 Other 7.5 $3.84 $28.80 $0.58      
 Calves 42.5 $2.54 $107.76 $2.16      
           
Total $100.00   $6.57 Total    $  - 
Reduced Revenue  Head $/Head Total $ $/Cow Reduced Cost Head $/Head Total $ $/Cow 
     
Morbidity 
Treatment     
     Cows/Other 1.725 $0.92 $1.58 $0.03 
     Calves 1.275 $0.94 $1.20 $0.02 
           
Total    $ - Total    $0.06 
Total Negative Effects    $6.57 
Total Positive 
Effects    $0.06 
     Net Gain or Loss Per Cow   $(6.52) 
          
*The only testing required is for any new cattle brought into the 
operation.        
 
Infected Herd Partial Budget  
 The cost of eradicating calves on a per cow basis are estimated using the value of the 
calves and is multiplied by the number of infected calves and divided by the number of cows in 




0.8333 of a calf and is then divided equally among the genders. That is then multiplied by the 
values of heifers and steers respectively and is divided by the number of cows in the herd (Table 
1). The calving percentages and the weaning weight percentages are assumed to be what the 
infection costs a herd in health. Meaning that a healthy herd has a calving percentage of 85 
percent. An infected herd has a decrease in calving percentage of 2 percent. Therefore, an 
infected herd has a calving percentage of (Infected Herd Calving Percentage) *1.02=0.85 of 
0.833. The determination is made by reducing the base healthy calving percentage by the 2 
percent that an infected herd would incur. An infected herd also has a 3 percent decrease in a 
weaning weight compared to a non-infected herd. The weaning weight increase in steers is 3 
percent which is (Steer Weaning Weight) *1.03=500 or 485.44. For heifers, (Heifer Weaning 
Weight) *1.03=475 or 461.12 to determine the decrease in weaning weight cost (Table 2). These 
numbers represent the loss in calving percentage and weaning weight in an infected herd 
compared to a non-infected herd produces. The adjustment in calving percentage and weaning 
weight percentages determine how an infected herd differs from a non-infected herd based on 
previous literature. By determining the calving and weaning weight percentages from the base 
assumptions of what a non-infected herd produces, we determine what the actual loss is for a 
producer with an infected herd.  
 In the infected cow-calf operation, the first assumption to consider is this is the first-year 
control program includes eradication of infected animals from the operation. This budget includes 
the cost of testing and vaccination in the additional cost portion of the budget. The additional cost 
includes the assumption that the first set of testing and vaccination will have minimal labor costs 
due to the processing that will already occur at the time of implementation. However, the second 
round of testing will incur labor costs. This is because cattle will have to be gathered and 
processed a second time. The labor costs are minimal due to the reduced amount of cattle that will 




gathering and processing them for the second round of testing. The reduced revenue portion is 
where the cost of eradicating the infected cows/other and calves is noted. Now, this will only 
occur within the first year of the control program because the remaining cattle will be BVDv-PI 
free and additional eradication will not be necessary. In the additional revenue section, the 
increased calving percentage and the increased weaning weight percentages will be accounted 
for. The reduced cost section will take the decreased morbidity and decreased mortality costs into 
account (Table 8). However, the benefits that are seen from implementing a control program will 
continue in the following years to increase revenue and reduce cost while the reduced revenue of 
eradication is a one-time occurrence. 
Table 13. Infected Cow-Calf Partial Budget (Total Head 2,000) 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Cow Additional Revenue Head 
$/Hea
d Total $ $/Cow 
Initial Testing     
Increased Calving 
Percentage 3%    
 Pooled Testing 11 $6.50 $71.50 $1.43 Steers 0.42 
$835.
65 $348.19 $6.96 
      Heifers 0.42 
$724.
28 $301.78 $6.04 
          
Additional Testing Avg     
Increased Weaning 
Weight 3%    
 Infected    
$      
1.99 Steers 309.47 $1.67 $517.21 $10.34 
 Labor    
$      
1.00 Heifers 293.99 $1.52 $448.28 $8.97 
Vaccination          
 Cows 50 $        3.84 
$   
191.99 
$      
3.84      
 Other 7.5 $        3.84 
$    
28.80 
$      
0.58      
 Calves x 2 42.5 $        2.54 
$   
107.76 
$      
2.16      
           
Total    
$    
10.99 Total    $         32.31 
Reduced Revenue  Head $/Head Total $ $/Cow Reduced Cost Head 
$/Hea
d Total $ $/Cow 
Eradication of Infected 
Animals     Morbidity Treatment     
 Cows/Other 1.125 $  1,002.00 
$1,127.2
5 
$    
22.55 Cows/Other 8.625 $3.67 $31.61 $0.63 
 Steers 3.1875 $    835.65 
$2,663.6
3 
$    
53.27 Calves 6.375 $3.76 $23.96 $0.48 
 Heifers 3.1875 $    724.28 
$2,308.6
4 
$    
46.17      
           
Total    $121.99 Total    $1.11 
Total Negative Effects    $132.98 Total Positive Effects    $ 33.42 
     Net Gain or Loss Per Cow   $(99.56) 
          
*This does not include additional identification costs such as 





 The second year of the infected cow-calf budget will look similar to the second year 
budget of a non-infected operation. The testing cost would only be necessary if the operation 
introduced any new cattle into the herd. An assumption that the producer doesn’t introduce any 
new animals indicates that the only additional cost will be the vaccinations required each year. 
This consists of one shot for a bred cow during pregnancy to prevent a PI calf infection and two 
vaccinations for calves, one at branding and a booster shot at weaning to prevent an acute 
infection. The operation went from an infected herd to a non-infected herd and the benefits of 
controlling the disease will continue on into the second year. The increased calving and weaning 
percentages will still be accounted for in the additional revenue. Since the operation is continuing 
a vaccination program, the morbidity costs are going to be lower so that will still be in the 
reduced cost section of the budget and with the decreased mortality (Table 14). 
Table 14. Infected Cow-Calf Partial Budget Year 2 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Cow Additional Revenue Head 
$/Hea
d Total $ $/Cow 
Initial Testing     
Increased Calving 
Percentage 3%    
New Cattle* 0 $0.65 $         -  Steers 0.42 
$835.6
5 $348.19 $6.96 
      Heifers 0.42 
$724.2
8 $ 301.78 $6.04 
Vaccination          
 Cows 50 $3.84 $191.99 $3.84 Increased Weaning Weight 3%    
 Other 7.5 $3.84 $28.80 $0.58 Steers 309.47 $1.67 $517.21 $10.34 
 Calves x 2 42.5 $2.54 $107.76 $2.16 Heifers 293.99 $1.52 $448.28 $8.97 
          
           
Total    $6.57 Total    $       32.31 
Reduced Revenue  Head $/Head Total $ $/Cow Reduced Cost Head 
$/Hea
d Total $ $/Cow 
     Morbidity Treatment     
     Cows/Other 8.625 $3.67 $31.61 $0.63 
     Calves 6.375 $3.76 $23.96 $0.48 
           
Total    $ - Total    $1.11 
Total Negative Effects    $6.57 Total Positive Effects    $ 33.42 




          
*The only testing required is for any new cattle brought into the 





 The implementation of the enhanced control program that assumed in these budgets will 
start in the fall during pregnancy testing of cows and weaning of calves. Meaning that the spring 
calves should have a higher weaning weight because they will not be surrounded by infected 
animals. The calving percentage would also increase due to the reduced exposure to the disease. 
This continues into the next year because the herd will reach the status that a non-infected herd 
would have which increases profits.   
Commercial Stocker Partial Budget 
 It is estimated that 69.2 percent of cattle that are brought into a commercial stocker 
operation before they are transported to a feedlot operation. In this simulation, the infected cattle 
that typically would have been in the retained stocker operations were subtracted from the 
retained and added to the commercial operations because the performance of the cattle is amounts 
to performance expected in a commercial operation compared to a retained stocker operation. As 
a result, the percentage of cattle in this simulation that is calculated to be from a commercial 
stocker operation is 69.3 percent (Table 12). The cattle that are brought into a stocker operation 
are vaccinated upon arrival. The vaccination cost has multiple components and was valued at 
$3.00 per head in the operation. Testing is not incorporated into this budget due to the testing that 
is incorporated in the cow-calf operations. Additional testing in a feedlot operation would be 




cost will still require vaccinations on a per head basis throughout the operation to continue 
management of the disease. The additional revenue accounts for the decrease in death-loss that is 
related to respiratory disease. This is accounted for using stocker values in the Oklahoma 
weighted average auction data. The estimated size of the commercial stocker operation in this 
current budget is 29,439 head of cattle, a total death-loss of 1.13 percent of the population and is 
distributed using a weighted average between steers and heifers (Peel, D.S., 2018 ‘A’). The 
reduced cost segment accounts for the reduced morbidity within the operation that is related to 
respiratory disease and is determined on a per head cost basis (Peel, D.S., 2018 ‘A’). The 
performance losses are based on previous literature on a per head basis over all animals. This 
estimation included infected animal losses along with the losses attributed to animals that were 
exposed to the disease on a per head basis (Table 15). 
Table 15. Commercial Stocker Partial Budget (Total Head 29,439) 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Total Head Additional Revenue Head $/Head Total $ $/Total Head 
Vaccination     Death-Loss 1.129%    
 Cattle 1 $3.00 $      3.00 $        3.00 Steers 212.88 $835.65 $177,894.50 $6.04 
     Heifers 119.53 $724.28 $86,572.31 $2.94 
          
           
Total    $        3.00 Total    $8.98 
Reduced Revenue  Head $/Head Total $ $/Total Head Reduced Cost Head $/Head Total $ $/Total Head 
     Morbidity Treatment 16.02%    
     Sick Cattle 4716.17 $20.40 $96,209.83 $3.27 
     Performance Losses 79%    
      23257.01 $25.00 $581,425.23 $19.75 
           
Total    $            - Total    $23.02 
Total Negative Effects    $       3.00 Total Positive Effects    $32.00 
     Net Gain or Loss    $29.00 
          
     Aggregate    $853,784.11 
 




 Some cattle are retained from non-infected cow-calf operations and kept on the operation 
as stockers before being sold directly to an auction or a feedlot which bypasses a commercial 
stocker operation. This differs from a commercial stocker operation because the death loss and 
morbidity incidence decrease since the cattle are not transported and comingled. These cattle have 
minimal exposure, therefore, they have minimal impacts inflicted by the disease. It is estimated 
that 30.8 percent of cattle that remain in a non-infected retained stocker operation before being 
sold to a feedlot. In this simulation, a total of 13,027 cattle remain in a retained operation. The 
incidence rate was applied to the stocker operations to determine that 1.02 retained stocker 
operations have BVDv infected cattle (Table 16). Those operations were added to the commercial 
stocker operations because the performance and morbidity would be on par with those operations 
compared to a non-infected retained operation. Therefore, in this simulation, the percentage of 
total cattle that are in a retained operation was reduced to 30.68 percent (Table 17). 
Table 16. Cattle throughout Simulation 
Operation Herds Cows Calving Percentage Calves  
Initial  1000     
 Infected Calves 40 2000 83.33% 1666.67  
 Non-Infected Calves 960 48000 85.00% 40800  
Total    42466.67  
Operation Percentage Herds Prevalence # of Operations  
Retained Stocker 30.80% 308 0.40% 1.232  
Commercial Stocker 69.20% 692 0.40% 2.768  
 Operation  Herds Percentage Distribution Animals in Operation Death-loss Survived to Feedlot 
Retained Stocker 306.77 30.68% 13027.41 1.00% 12897.14 
 Commercial Stocker  693.23 69.32% 29439.25 2.46% 28715.05 













Table 17. Retained Stocker Partial Budget (Total Head 13,027) 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Total Head Additional Revenue Head $/Head Total $ $/Total Head 
Vaccination     Death-Loss 0.46% 59.80   
Any additional Cattle 0 $3.00 $ - $ - Steers 38.29 $835.65 $32,000.65 $2.46 
     Heifers 21.50 $724.28 $15,573.11 $1.20 
          
           
Total    $        - Total    $3.65 
Reduced Revenue  Head $/Head Total $ $/Total Head Reduced Cost Head $/Head Total $ $/Total Head 
     Morbidity Treatment 1.00%    
     Sick Cattle 130.27 $20.40 $     2,657.59 $0.20 
     Performance Losses 1%    
      130.27 $      25.00 $     3,256.85 $0.25 
           
Total    $ - Total    $0.45 
Total Negative Effects    $ - Total Positive Effects    $4.11 
     Net Gain or Loss    $4.11 
          
     Aggregate    $ 53,488.21 
 
Feedlot Partial Budget 
 The cattle that are brought into a feedlot operation were vaccinated upon arrival. The 
vaccination cost was valued at $4.00 per head in the operation. Testing was not incorporated into 
this budget due to the testing that was incorporated in the cow-calf operations. Addition testing in 




cow-calf level. The additional cost still required vaccinations on a per head basis throughout the 
operation to maintain adequate management of the disease. The additional revenue accounts for 
the decrease in death-loss that is related to respiratory disease. These were valued for using 
Oklahoma weighted average auction data. Feedlots are assumed to have a total death-loss of 1.43 
percent of the population and was distributed using a weighted average between steers and 
heifers. The reduced cost segment accounted for the reduced morbidity within the operation that 
was related to respiratory disease and was determined on a per head cost basis. The performance 
losses were estimated through the previous literature on a per head basis over all animals. This 
estimation included infected animal losses along with the losses attributed to animals that were 
exposed to the disease in a cost per head basis (Table 18). 
Table 18. Feedlot Partial Budget (Total Head 41,612) 
Negative Effects:      Positive effects:     
Additional Cost  Head $/Head Total $ $/Total Head Additional Revenue Head $/Head Total $ $/Total Head 
Vaccination     Death-Loss 0.66% 273.129911   
 Cattle 1 $4.00 $4.00 $4.00 Steers 174.92 $1,188.00 $207,801.77 $4.99 
     Heifers 98.21 $1,076.34 $105,709.90 $ 2.54 
     Chronic 0.587%    
     Cattle 244.06 $212.50 $51,861.79 $1.25 
           
Total    $4.00 Total    $8.78 
Reduced Revenue  Head $/Head Total $ $/Total Head Reduced Cost Head $/Head Total $ $/Total Head 
     Morbidity Treatment 15%    
     Sick Cattle 6241.83 $26.40 $164,784.26 $3.96 
     Performance Losses 79%    
      32873.63 $53.38 $1,754,629.88 $42.17 
           
Total    $ - Total    $             46.13 
Total Negative Effects    $4.00 Total Positive Effects    $            54.91 
     Net Gain or Loss    $          50.91 
          
     Aggregate    $  2,118,338.85 






















RESULTS AND CONCLUSIONS 
Results 
 In the previous section, the budgets and their components were discussed and evaluated 
to assess how the different components changed the value of the enhanced control program 
implementation.  
Non-infected Cow-Calf Operation Year 1 
Given that 96 percent of cow-calf operations are uninfected, this is the most common 
outcome for cow-calf producer and this budget represents what happened for these producers 
assuming they implemented an enhanced control program into their operation. The net gain of 
introducing an enhanced BVDv control program resulted in a net loss for the non-infected cow-
calf producer of $7.64 per cow. This cost was primarily associated with the initial cost of testing 
along with the vaccination program (Table 11). 




The net loss in the second year for the non-infected cow-calf producer was $6.46 per 
cow. Year 2 does not include testing costs for the operation. Vaccinations were a reoccurring cost 
for operations to maintain the optimum enhanced control. This budget showed the amount that 
producers would require as an incentive to maintain control of the disease (Table 12). 
Infected Cow-Calf Year 1 
Infected cow-calf herds had BVDv incidence and were operating below optimal 
production capacity relative to a non-infected operations. Multiple impacts result from the disease 
such as calving and weaning weight reductions as well as overall productivity. The calving 
percentage increase amounted to approximately $13.00 per cow because an infected herd had 
about 3 percent less of a calving percentage compared to a non-infected herd (Table 2). There 
was also an impact on the weaning weight percentage of about 3 percent for both heifers and 
steers (Table 2). In this budget, the cost of eradicating infected animals is incorporated into the 
reduced revenue section of the operation. The cost per cow of eradicating infected mature animals 
was $22.55 (Table 1). The cost of eradicating infected steers and heifer on a per cow basis was 
$99.45 (Table 1). The testing costs were higher compared to a non-infected herd because of the 
second round of testing required which also incurred additional labor costs to gather and process 
the cattle. However, the increased calving and weaning percentages help alleviate the added costs 
of testing and eradicating the disease along with vaccination. The first year in this budget analysis 
found that the cost of implementing a control program resulted in a net loss in the first year of 
$96.21 per cow for an infected cow-calf operation (Table 13). 
Infected Cow-Calf Year 2 
 The second year of the infected cow-calf operation was similar to the second year of the 
non-infected cow-calf operation. The testing costs are only required for new cattle and the 




from eradicating the disease in the second year. After year two, they will stay at the same level as 
the non-infected operation. The benefits derived from the increased productivity of the herd. The 
net gain for the infected cow-calf producer in the second year of the control program was $27.96 
per cow (Table 14). 
Commercial Stocker 
 The commercial stocker operation is where the first round of major comingling occurs in 
the beef industry. Therefore, cattle that are BVDv-PI positive sheds the disease to all animals it 
encountered. In a BVDv positive environment, feedlot data show that 79 percent of all animals 
are exposed to BVDv. BVDv exposure is at least as high in stocker operations or perhaps higher 
since animals tend to be commingled into larger grazing groups. The production, morbidity and 
mortality losses caused by BVDv show how detrimental the impacts are in this sector. In a 
commercial feedlot operation, 1.129 percent of all death loss was attributed to BVDv (Table 12) 
and morbidity was at 16.02 percent (Table 17). The net gain that a commercial stocker operation 
observed from this enhanced control program was $48.89 per head (Table 15). 
Retained Stocker 
 Since infected cattle were removed at the cow-calf level, the impacts on non-infected 
retained calves is small for retained stocker operations. The death-loss and morbidity still had a 
small presence assuming acute infections were still possible through fence-line contact. The net 
gain for retained stocker operations was $4.39 per head (Table 17). 
Feedlot 
 The largest impact of BVDv occurred at the feedlot level. This was where all cattle 
commingled and the most likely scenario for the disease to manifest. Morbidity, mortality and 




disease. The loss of productivity was the largest impact, which accounted for 84 percent of 
feedlot losses due to BVDv. The net gain for a feedlot operation was $50.28 per head (Table 18).  
 
Aggregate Market Impacts 
 Even though the non-infected herds were more likely, and the cost of enhanced control 
seemed to be a net loss, the outcome, in the end, shows that enhanced control would ultimately be 
a cost-effective endeavor across the entire industry. The effect of the disease was most severe at 
the stocker and feedlot levels of the industry, yet the most effective control occurred at the cow-
calf level. In this simulation, a cow produces 414.375-pounds of calf when the weight was 
averaged between steers and heifers and then adjusted by the calving percentage. This averaged 
out to 4.14 hundredweight (Table 19). The cost of enhanced control in the first year for non-
infected cow-calf operations is $7.64 per cow.  After dividing the cost of the pounds per cow 
produced, the resulting premium that would be needed to cover the cost of enhanced control is 
$1.84 per hundredweight (Table 19). This would only be required in the first year. The cost of 
control in the second year was $6.46, therefore, the premium required would be $1.56. For an 
infected cow-calf operation, the valuation of implementing an enhanced control program into 
their operations had a negative value in the first year and then a positive value the next year. 
Assuming a discount rate of 4 percent over ten years, the net present value of the implementation 
was $107.39 per cow in the operation (Table 20).  
Table 19. Average Pounds of Calf Produced Per Cow 
Calving % Avg lbs of Calf Avg lbs Per Cow Pounds per CWT Cost Per Cow Non-Infected Premium Per CWT 
85% 487.5 414.375 4.14375 $(7.95) $(1.92) 
    $(6.52) $(1.57) 
 




Year Value Rate of Return NPV 
1 $                        (99.56) 0.04 $96.23 
2 $                         26.85   
3 $                         26.85   
4 $                         26.85   
5 $                         26.85   
6 $                         26.85   
7 $                         26.85   
8 $                         26.85   
9 $                         26.85   
10 $                         26.85   
 
 By evaluating the numbers on an individual basis for each sector and for individual head, 
the impacts are on a smaller scale. By applying the numbers to the full capacity of a simulation, 
the impacts are visible. For 96 percent of the population, the cost of implementing this control 
program is $366,801.68 (Table 11). For the 4 percent of the population, the cost of implementing 
this program is $192,422.45 (Table 12). However, the gain for commercial stocker operations is 
$779,299.83, for retained stockers it is $53,488.21, and for feedlots it is $2,092,102.88 (Tables 
15, 17, 18).  
 By evaluating the costs in both the non-infected and infected cow-calf operations, the 
total cost would be $559,224.12 or $5.76 per every animal in the simulation (Table 21). The total 
benefit to the commercial stockers, retained stockers and feedlots is $2,999,375.21 or $29.99 per 
every animal in the simulation (Table 21). The total net benefit of implementing the enhanced 
control in this simulation is $2,423,766.99 across all sectors or $24.24 per animal in the 
simulation (Table 21). 
Table 21. Aggregate BVDv Impacts from Simulation 
Operation Cost Benefit 
Non-Infected Cow-Calf $(381,381.92)  
Infected Cow-Calf $(199,116.74)  
Retained Stocker  $53,488.21 
Commercial Stocker   $853,784.11 




 Total $(580,498.67) $3,025,611.17 
Cost per every animal $(5.80)  
Benefit per every animal  $30.26 
Net total benefit  $2,445,112.51 
Net benefit per animal  $24.45 
 
Conclusions and Industry Implications 
 The results of this analysis confirm that the current level of BVDv control in the beef 
industry is less than optimal. The unequal distribution of costs and benefits across beef 
production sectors, combined with under recognized BVDv impacts at all levels is causing a 
market failure that results in a sub-optimal level of BVDv control. The budget analysis suggests 
that at the aggregate level, there is ample value in controlling the disease at the stocker and 
feedlot levels which could compensate cow-calf producers for implementation of a control 
program. This leads to the question of how the benefits can be redistributed to provide additional 
incentives for enhanced BVDv control.  
 The cattle industry consists of complex production processes across all sectors. The 
implementation of the control program must start at the cow-calf operation to control the 
production of PI cattle. However, demand for reduced BVDv-PI animals will have to be at the 
stocker and feedlot operations. If the demand for BVDv free cattle starts with feedlots and 
stockers, then cow-calf producers will follow suit to meet demand. Even though change can be 
hard to adapt to, if operations are not paying for infected cattle, they producers will adapt and 
produce a desired product.  
Once control is implemented in the cow-calf sector, the infected animals will be 
eradicated and that will be the last year of infected animals in the cow-calf sector. However, the 
infected cattle will still be moving throughout stocker/backgrounding and feedlot operations. The 
infected cattle will remain within those operations until the non-infected batch of animals from 




implementation of the enhanced control program. The budgets and profile of implementing the 
control program are based on a breeding year cycle. The testing occurs in June when branding is 
taking place just before the bulls are placed back into the herd for the new cycle. Infected cows 
and calves are identified within the herd and disposed of. The operation will then see the benefits 
of the disease control within the next year. Calving percentage will increase because all cows are 
vaccinated against acute infections and the presence of PI cattle will be non-existent. Weaning 
weights will increase in the next year as well because of the lack of exposure and 
immunosuppression. If a producer would wait until October or weaning, the budgets would 
incorporate an additional year until the benefits of eradicating the disease were visible. The cycle 
would be pushed back and the effects of the disease would have already affected the calf crop on 
the ground and the cattle that are pregnant with the upcoming calf crop.   
 The mental approach that should be used to this control situation is similar to a financial 
investment situation. The first year will require sacrifice in order to obtain the maximum benefit 
of the program. This sacrifice constitutes the eradication of the infected animals from the herd. 
This will cause a loss for the producer in the first year because the infected cattle should be 
eliminated to deter any further spread of infection. The second year will be when the benefits are 
recognized. Overall herd health and profit will increase which benefits the producer throughout 
the following years. Over time, the enhanced control of the disease will reap more benefits than 
the initial incurred costs.  
Market failure is extensive throughout the sectors in this disease control issue. The cost 
of implementation and control resides predominately on the cow-calf sector in the beef industry. 
However, the stocker and feedlot operations would benefit extensively. This disconnect occurs 
because the majority of cow-calf producers do not receive any benefits for disease control since 
96 percent of the operations are not infected. Only infected operations see benefits from 




mass performance loss across an operation where there is extensive commingling. This is why 
there would be such a large benefit for feedlots and stockers to control the disease by reducing 
those losses from occurring. Once an optimal solution is reached in the market, the impacts 
should be neutralized and the cost of controlling the disease will be reduced. The majority of the 
cost to control the disease will occur within the first year. Beyond that, the cost of control will be 
minimal with the same benefits. However, the largest issue will be producing a benefit that will 
entice cow-calf producers to implement the enhanced control program. 
 
Limitations on Work 
The greatest limitation of this research is even though veterinary knowledge about the 
disease itself is extensive, the economic information on the disease was variable, inconsistent and 
far-reaching. The biggest issue was determining where the initial economic assumptions should 
stem from because the literature was inconsistent.  Therefore, a large part of this simulation is 
based on assumptions that were determined using the available resources. The assumptions might 
seem high and extensive in multiple parts such as the performance losses. However, the cost of 
implementing the control program would still be plausible even if the benefits of control were cut 
in half or a third of the original assumption. The second largest issue with determining the 
economic impact of BVDv is the fact that BRD and BVDv are so closely aligned and there is not 
an extensive amount of specific definition of the two diseases. BRD is amplified through BVDv 
immunosuppression, however, this is not necessarily specifically quantified. This makes 
determining the actual economic value difficult. Most of the previous literature focuses on a 
particular section or sector of the beef industry.  This analysis synthesized the expanse of the 
industry to determine what impacts occurred on every level and how the market failure was 




specific sectors while trying to evaluate the implications that followed a disease through all 
sectors. The third issue that limited the research was the number of assumptions based on 
previous literature. There is not an all-inclusive literature source that depicts the disease impacts 
and issues through all three of the sectors. Assumptions were pulled and made through multiple 
sources that had a variety of ranges incorporating the disease costs and impacts. The final limiting 
factor of this research is that the disease itself is constantly changing and evolving along with 
research. The costs of testing and vaccination are currently up to date, however, this will not 
remain so for long. The research and understanding that incorporates the disease is constantly 
changing because of its complexity and severity of its impacts. That makes this an ever-changing 
project that is just as fluid as the disease.  
Suggestions for Further Work 
 This research can be expanded in multiple ways. First, a full breakdown of the benefits 
and costs associated with BRD, BVDv and BVDv-PI and how much they differ would be useful. 
The second topic is how much the disease would be costing the industry if uncontrolled, 
including the implications of losses for the next ten years. The other interesting topic is a full 
economic valuation of the production losses associated with BVDv alone. The losses are not 
excessively detailed and the assumptions of the losses are only based off of a few studies. 
Another implication of the enhanced control implementation is the effect that it would have on 
the beef cattle price market. If the disease was controlled at the cow-calf level, it would be 
assumed that the death-loss, morbidity and production losses would all be alleviated from it. This 
would cause a shift in the price structure of the beef industry. Supply would increase by a 
substantial amount without a shift in demand. This would shift the market structure and the price 
would change to reflect the shift in supply. The increased supply causes a surplus of beef that 
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